Hannes Hagström | Karolinska Institutet

Om mig
Publikationer
Forskningsbidrag
CV
Populärvetenskap och samverkan

Om mig

Adjungerad professor och biträdande överläkare inom hepatologi. Jag tog min doktorsexamen vid Karolinska Institutet 2007 och är specialist inom hepatologi. Jag försvarade min avhandling 2016 och är docent i hepatologi sedan 2019, med en adjungerad professur sedan 2024. Jag leder en forskargrupp vid avdelningen för gastroenterologi och reumatologi vid institutionen för medicin, Huddinge. Nuvarande projekt fokuserar på epidemiologin vid MASLD där vår grupp har varit med och skapat några av de globalt största kohorterna och vi har ett brett internationellt nätverk. Jag har flertal uppdrag inom svensk gastroenterologi och har bland annat ansvarat för att ta fram svenska riktlinjer för MASLD.
Mer information finns på den engelska profilsidan

Artiklar

Journal article: INTERNATIONAL JOURNAL OF CANCER. 2025;156(1):40-51
Metabolic dysfunction-associated steatotic liver disease has become the most common cause of hepatocellular carcinoma in Sweden: A nationwide cohort study
Vaz J; Jepsen P; Stromberg U; Midlov P; Eriksson B; Buchebner D; Hagstrom H
Journal article: CLINICAL GASTROENTEROLOGY AND HEPATOLOGY. 2024;22(11):2352-2353
Reply.
Nasr P; Hagström H
Article: LIVER INTERNATIONAL. 2024;44(11):3050-3059
Socioeconomic factors associated with the presence of and outcomes in metabolic dysfunction-associated steatotic liver disease
Nasr P; Shang Y; Wester A; Strandberg R; Widman L; Lazarus JV; Hagstrom H
Journal article: GUT. 2024;73(11):1883-1892
Long-term liver-related outcomes and liver stiffness progression of statin usage in steatotic liver disease
Zhou X-D; Kim SU; Yip TC-F; Petta S; Nakajima A; Tsochatzis E; Boursier J; Bugianesi E; Hagstrom H; Chan WK; Romero-Gomez M; Calleja JL; de Ledinghen V; Castera L; Sanyal AJ; Goh GB-B; Newsome PN; Fan J; Lai M; Fournier-Poizat C; Lee HW; Wong GL-H; Armandi A; Shang Y; Pennisi G; Llop E; Yoneda M; de Saint-Loup M; Canivet CM; Lara-Romero C; Gallego-Duran R; Asgharpour A; Teh KK-J; Mahgoub S; Chan MS-W; Lin H; Liu W-Y; Targher G; Byrne CD; Wong VW-S; Zheng M-H
Article: LIVER INTERNATIONAL. 2024;44(10):2551-2563
Persons with metabolic dysfunction-associated steatotic liver disease are at increased risk of severe depression
Astrom H; Shang Y; Hagstrom H; Wester A
Journal article: THE LANCET GASTROENTEROLOGY AND HEPATOLOGY. 2024;9(10):944-956
Natural history and progression of metabolic dysfunction-associated steatotic liver disease.
Hagström H; Shang Y; Hegmar H; Nasr P
Journal article: BRITISH JOURNAL OF NUTRITION. 2024;132(4):1-13
Associations between dietary fatty acid and plasma fatty acid composition in non-alcoholic fatty liver disease: secondary analysis from a randomised trial with a hypoenergetic low-carbohydrate high-fat and intermittent fasting diet
Tillander V; Holmer M; Hagstrom H; Petersson S; Brismar TB; Stal P; Lindqvist C
Article: JAMA NETWORK OPEN. 2024;7(9):e2432420
Birth Weight, Gestational Age, and Risk of Pediatric-Onset MASLD
Ebrahimi F; Yao J; Hagstroem H; Stephansson O; Sun J; Bergman D; Soderling J; Ludvigsson JF
Journal article: HEPATOLOGY. 2024
Association between longitudinal biomarkers and major adverse liver outcomes in patients with non-cirrhotic metabolic dysfunction-associated steatotic liver disease
Shang Y; Akbari C; Dodd M; Zhang X; Wang T; Jemielita T; Fernandes G; Engel SS; Nasr P; Vessby J; Rorsman F; Kechagias S; Stal P; Ekstedt M; Hagstrom H
Article: JOURNAL OF INTERNAL MEDICINE. 2024;296(2):177-186
Performance of novel collagen turnover biomarkers to detect increased liver stiffness in MASLD
Hegmar H; Wiggers T; Nasr P; Vessby J; Kechagias S; Nyhlin N; Marschall H-U; Borssen AD; Strandberg R; Karsdal M; Leeming DJ; Ekstedt M; Hagstrom H
Article: LIVER INTERNATIONAL. 2024;44(8):2002-2010
Statin initiation after myocardial infarction in patients with alcohol-related liver disease: A nationwide population-based study
Wester A; Jepsen P; Hagstrom H
Article: LIVER INTERNATIONAL. 2024;44(8):1872-1885
Diagnostic accuracy of non-invasive tests to screen for at-risk MASH-An individual participant data meta-analysis
Mozes FE; Lee JA; Vali Y; Selvaraj EA; Jayaswal ANA; Boursier J; de Ledinghen V; Lupsor-Platon M; Yilmaz Y; Chan W-K; Mahadeva S; Karlas T; Wiegand J; Tsochatzis E; Liguori A; Wong VW-S; Lee DH; Holleboom AG; van Dijk A-M; Mak AL; Hagstroem H; Akbari C; Hirooka M; Lee DH; Kim W; Okanoue T; Shima T; Nakajima A; Yoneda M; Thuluvath PJ; Li F; Berzigotti A; Mendoza YP; Noureddin M; Truong E; Fournier-Poizat C; Geier A; Tuthill T; Yunis C; Anstee QM; Harrison SA; Bossuyt PM; Pavlides M
Journal article: CLINICAL GASTROENTEROLOGY AND HEPATOLOGY. 2024;:S1542-3565(24)00679-7
Biomarkers for Prediction of Alcohol-Related Liver Cirrhosis: A General Population-Based Swedish Study of 537,250 Individuals.
Jakobsson G; Talbäck M; Hammar N; Shang Y; Hagström H
Article: LIVER INTERNATIONAL. 2024;44(7):1689-1699
Liver stiffness predicts progression to liver-related events in patients with chronic liver disease - A cohort study of 14 414 patients
Hegmar H; Wester A; Aleman S; Backman J; Degerman E; Ekvall H; Lund K; Lundgren A; Nasr P; Shahnavaz A; Vessby J; Westin J; Onnerhag K; Hagstrom H
Article: DIABETES CARE. 2024;47(6):978-985
Metabolic Syndrome Traits Increase the Risk of Major Adverse Liver Outcomes in Type 2 Diabetes
Shang Y; Grip ET; Modica A; Skroder H; Strom O; Ntanios F; Gudbjornsdottir S; Hagstrom H
Journal article: HEPATOLOGY COMMUNICATIONS. 2024;8(6):e0423
Liver histology is associated with long-term clinical outcomes in patients with metabolic dysfunction-associated steatohepatitis
Younossi ZM; Mangla KK; Berentzen TL; Grau K; Kjaer MS; Ladelund S; Nitze LM; Coolbaugh C; Hsu C-Y; Hagstrom H
Journal article: JOURNAL OF HEPATOLOGY. 2024;80:s40
OS-057-YI CORE: a new risk score measuring GGT, AST, and ALT outperforms FIB-4 when predicting the risk of cirrhosis in a primary care setting
Strandberg R; Talbäck M; Hammar N; Hagström H
Article: LIVER INTERNATIONAL. 2024;44(5):1253-1264
Risk of major adverse liver outcomes among first-degree relatives of individuals with MASLD
Yang W; Ebrahimi F; Romeo S; Holmer M; Vessby J; Ekstedt M; Ludvigsson JF; Shang Y; Hagstrom H
Article: CLINICAL GASTROENTEROLOGY AND HEPATOLOGY. 2024;22(5):1048-1057.e2
Misclassified Alcohol-related Liver Disease is Common in Presumed Metabolic Dysfunction-associated Steatotic Liver Disease and Highly Increases Risk for Future Cirrhosis
Nasr P; Wester A; Ekstedt M; Strandberg R; Kechagias S; Shang Y; Widman L; Hagstrom H
Article: ALIMENTARY PHARMACOLOGY AND THERAPEUTICS. 2024;59(9):1111-1121
Prevalence and risk factors of metabolic dysfunction-associated steatotic liver disease in south Central Uganda: A cross-sectional survey
Enriquez R; Homsi M; Ssekubugu R; Nabukalu D; Zeebari Z; Marrone G; Gigante B; Chang LW; Reynolds SJ; Nalugoda F; Ekstroem AM; Hagstroem H; Nordenstedt H
Article: JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (JAMA). 2024;331(15):1287-1297
Vibration-Controlled Transient Elastography Scores to Predict Liver-Related Events in Steatotic Liver Disease
Lin H; Lee HW; Yip TC-F; Tsochatzis E; Petta S; Bugianesi E; Yoneda M; Zheng M-H; Hagstrom H; Boursier J; Calleja JL; Goh GB-B; Chan W-K; Gallego-Duran R; Sanyal AJ; de Ledinghen V; Newsome PN; Fan J-G; Castera L; Lai M; Harrison SA; Fournier-Poizat C; Wong GL-H; Pennisi G; Armandi A; Nakajima A; Liu W-Y; Shang Y; de Saint-Loup M; Llop E; Teh KK-J; Lara-Romero C; Asgharpour A; Mahgoub S; Chan MS-W; Canivet CM; Romero-Gomez M; Kim SU; Wong VW-S
Article: GUT. 2024;73(5):825-834
Serum ferritin levels can predict long-term outcomes in patients with metabolic dysfunction-associated steatotic liver disease
Armandi A; Sanavia T; Younes R; Caviglia GP; Rosso C; Govaere O; Liguori A; Francione P; Gallego-Duran R; Ampuero J; Pennisi G; Aller R; Tiniakos D; Burt A; David E; Vecchio F; Maggioni M; Cabibi D; Mcleod D; Pareja MJ; Zaki MYW; Stal P; Kechagias S; Fracanzani AL; Valenti L; Grieco A; Miele L; Fariselli P; Eslam M; Petta S; Hagstroem H; George J; Schattenberg JM; Romero-Gomez M; Anstee QM; Bugianesi E
Article: GUT. 2024;73(5):835-843
Glucagon-like peptide-1 receptor agonists and risk of major adverse liver outcomes in patients with chronic liver disease and type 2 diabetes
Wester A; Shang Y; Grip ET; Matthews AA; Hagstrom H
Article: CLINICAL GASTROENTEROLOGY AND HEPATOLOGY. 2024;22(4):749-759.e19
Statins Are Associated With a Decreased Risk of Severe Liver Disease in Individuals With Noncirrhotic Chronic Liver Disease
Sharma R; Simon TG; Hagstrom H; Lochhead P; Roelstraete B; Soderling J; Verna EC; Emond J; Ludvigsson JF
Article: ADDICTION. 2024;119(4):706-716
Disentangling the contributions of alcohol use disorder and alcohol-related liver disease towards dementia: A population-based cohort study
Zhao S; Widman L; Hagstrom H; Shang Y
Article: MOLECULAR SYSTEMS BIOLOGY. 2024;20(4):374-402
Estrogen receptor activation remodels TEAD1 gene expression to alleviate hepatic steatosis
Sommerauer C; Gallardo-Dodd CJ; Savva C; Hases L; Birgersson M; Indukuri R; Shen JX; Carravilla P; Geng K; Sondergaard JN; Ferrer-Aumatell C; Mercier G; Sezgin E; Korach-Andre M; Petersson C; Hagstrom H; Lauschke VM; Archer A; Williams C; Kutter C
Article: HEPATOLOGY. 2024;79(2):502-523
A global action agenda for turning the tide on fatty liver disease
Lazarus JV; Mark HE; Allen AM; Arab JP; Carrieri P; Noureddin M; Alazawi W; Alkhouri N; Alqahtani SA; Anstee QM; Arrese M; Bataller R; Berg T; Brennan PN; Burra P; Castro-Narro GE; Cortez-Pinto H; Cusi K; Dedes N; Duseja A; Francque SM; Gastaldelli A; Hagstrom H; Huang TTK; Wajcman DI; Kautz A; Kopka CJ; Krag A; Newsome PN; Rinella ME; Romero D; Sarin SK; Silva M; Spearman CW; Terrault NA; Tsochatzis EA; Valenti L; Villota-Rivas M; Zelber-Sagi S; Schattenberg JM; Wong VW-S; Younossi ZM
Article: JHEP REPORTS. 2024;6(2):100915
Long-term major adverse liver outcomes in 1,260 patients with non-cirrhotic NAFLD
Akbari C; Dodd M; Stal P; Nasr P; Ekstedt M; Kechagias S; Vessby J; Rorsman F; Zhang X; Wang T; Jemielita T; Fernandes G; Engel SS; Hagstrom H; Shang Y
Article: HEPATOLOGY COMMUNICATIONS. 2024;8(2):e0386
The future of International Classification of Diseases coding in steatotic liver disease: An expert panel Delphi consensus statement
Hagstrom H; Adams LA; Allen AM; Byrne CD; Chang Y; Duseja A; Gronbaek H; Ismail MH; Jepsen P; Kanwal F; Kramer J; Loomba R; Mark HE; Newsome PN; Rinella ME; Rowe IA; Ryu S; Sanyal A; Schattenberg JM; Serper M; Sheron N; Simon TG; Spearman CW; Tapper EB; Villota-Rivas M; Wild SH; Wong VW-S; Yilmaz Y; Zelber-Sagi S; Aberg F; Lazarus JV
Journal article: GASTRO HEP ADVANCES. 2024;3(6):783-792
Lower Incidence of HCC and Other Major Adverse Liver Outcomes in People Living With HIV and Chronic Liver Disease.
Michel M; Hagström H; Widman L; Nowak P; Shang Y; Schattenberg JM; Wester A
Article: PLOS ONE. 2024;19(5):e0294695
Evaluation of mucosal-associated invariant T-cells as a potential biomarker to predict infection risk in liver cirrhosis
Bengtsson B; Maucourant C; Sandberg JK; Bjorkstrom NK; Hagstrom H
Article: THE LANCET GASTROENTEROLOGY AND HEPATOLOGY. 2024;9(1):83-91
Implementation of a liver health check in people with type 2 diabetes
Abeysekera KWM; Valenti L; Younossi Z; Dillon JF; Allen AM; Noureddin M; Rinella ME; Tacke F; Francque S; Gines P; Thiele M; Newsome PN; Guha IN; Eslam M; Schattenberg JM; Alqahtani SA; Arrese M; Berzigotti A; Holleboom AG; Caussy C; Cusi K; Roden M; Hagstroem H; Wong VW-S; Mallet V; Castera L; Lazarus JV; Tsochatzis EA
Article: CARDIOVASCULAR DIABETOLOGY. 2023;22(1):343
Incident cardiac arrhythmias associated with metabolic dysfunction-associated steatotic liver disease: a nationwide histology cohort study
Simon TG; Ebrahimi F; Roelstraete B; Hagstrom H; Sundstrom J; Ludvigsson JF
Article: JOURNAL OF HEPATOLOGY. 2023;79(6):1366-1373
Progression of non-alcoholic fatty liver disease and long-term outcomes: A nationwide paired liver biopsy cohort study
Simon TG; Roelstraete B; Hagstroem H; Loomba R; Ludvigsson JF
Article: CLINICAL GASTROENTEROLOGY AND HEPATOLOGY. 2023;21(13):3346-3355.e19
Risk of Severe Infection in Patients With Biopsy-proven Nonalcoholic Fatty Liver Disease - A Population-based Cohort Study
Ebrahimi F; Simon TG; Hagstrom H; Soderling J; Wester A; Roelstraete B; Ludvigsson JF
Article: CLINICAL GASTROENTEROLOGY AND HEPATOLOGY. 2023;21(13):3336-3345.e2
Secondary Prevention of Esophageal Variceal Bleeding Is Often Imperfect: A National, Population-Based Cohort Study of 3592 Patients
Hagstroem H; Shang Y; Tapper EB; Wester A; Widman L
Article: JOURNAL OF HEPATOLOGY. 2023;79(6):1374-1384
Familial coaggregation of MASLD with hepatocellular carcinoma and adverse liver outcomes: Nationwide multigenerational cohort study
Ebrahimi F; Hagstrom H; Sun J; Bergman D; Shang Y; Yang W; Roelstraete B; Ludvigsson JF
Journal article: EUROPEAN HEART JOURNAL. 2023;44:ehad655.2647
The incidence of coronary artery disease in all Swedish liver transplant patients between 1987 and 2020: A national prospective study
Lewinter C; Widman L; Hagstrom H
Journal article: EUROPEAN HEART JOURNAL. 2023;44:ehad655.2648
The incidence of coronary artery disease after liver transplant: a meta-analysis
Tabulo Z; Hagstrom H; Braunschweig F; Lewinter C
Journal article: CANADIAN JOURNAL OF DIABETES. 2023;47(7):s200-s201
THE RELATIONSHIP BETWEEN LIVER HISTOLOGY AND LONG-TERM CLINICAL OUTCOMES IN PATIENTS WITH NON-ALCOHOLIC STEATOHEPATITIS: A REAL-WORLD COHORT STUDY
McLeod M; Younossi Z; Mangla K; Berentzen T; Grau K; Kjaer M; Ladelund S; Nitze L; Coolbaugh C; Hsu C; Hagström H
Article: HEPATOLOGY COMMUNICATIONS. 2023;7(11):e0238
Risk of injuries before and after a diagnosis of cirrhosis: A population-based cohort study
Shang Y; Shen Q; Tapper EB; Wester A; Hagstrom H
Article: UNITED EUROPEAN GASTROENTEROLOGY JOURNAL. 2023;11(9):852-860
Four-fold increased mortality rate in patients with Wilson's disease: A population-based cohort study of 151 patients
Aberg F; Shang Y; Strandberg R; Wester A; Widman L; Hagstrom H
Journal article: CANADIAN JOURNAL OF CARDIOLOGY. 2023;39(10):s241
THE RELATIONSHIP BETWEEN LIVER HISTOLOGY AND LONG-TERM CLINICAL OUTCOMES IN PATIENTS WITH NON-ALCOHOLIC STEATOHEPATITIS: A REAL-WORLD COHORT STUDY
McLeod M; Younossi Z; Mangla K; Berentzen T; Grau K; Kjaer M; Ladelund S; Nitze L; Coolbaugh C; Hsu C; Hagström H
Article: LIVER INTERNATIONAL. 2023;43(10):2142-2152
Risk of infections in non-alcoholic fatty liver disease: A nationwide population-based cohort study
Shang Y; Widman L; Ebrahimi F; Ludvigsson JF; Hagstrom H; Wester A
Article: LIVER INTERNATIONAL. 2023;43(10):2186-2197
Antibiotic use and development of nonalcoholic fatty liver disease: A population-based case-control study
Ebrahimi F; Simon TG; Hagstrom H; Sun J; Bergman D; Forss A; Roelstraete B; Engstrand L; Ludvigsson JF
Article: HEPATOLOGY COMMUNICATIONS. 2023;7(10):e0279
Time trends in mortality and life expectancy in 22,658 patients hospitalized with alcohol-associated cirrhosis: A nationwide cohort study
Wester A; Shang Y; Stal P; Hagstrom H
Article: JOURNAL OF HEPATOLOGY. 2023;79(3):618-634
A global research priority agenda to advance public health responses to fatty liver disease
Lazarus JV; Mark HE; Allen AM; Arab JP; Carrieri P; Noureddin M; Alazawi W; Alkhouri N; Alqahtani SA; Arrese M; Bataller R; Berg T; Brennan PN; Burra P; Castro-Narro GE; Cortez-Pinto H; Cusi K; Dedes N; Duseja A; Francque SM; Hagstrom H; Huang TT-K; Wajcman DI; Kautz A; Kopka CJ; Krag A; Miller V; Newsome PN; Rinella ME; Romero D; Sarin SK; Silva M; Spearman CW; Tsochatzis EA; Valenti L; Villota-Rivas M; Zelber-Sagi S; Schattenberg JM; Wong VW-S; Younossi ZM
Article: EUROPEAN JOURNAL OF EPIDEMIOLOGY (EJE). 2023;38(9):973-984
Incidence, prevalence and mortality of chronic liver diseases in Sweden between 2005 and 2019
Nasr P; von Seth E; Mayerhofer R; Ndegwa N; Ludvigsson JFF; Hagstrom H
Article: SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY. 2023;58(8):931-936
Administrative coding for non-alcoholic fatty liver disease is accurate in Swedish patients
Astrom H; Wester A; Hagstrom H
Article: JOURNAL OF INTERNAL MEDICINE. 2023;294(2):164-177
Risk of fractures and postfracture mortality in 3980 people with primary biliary cholangitis: A population-based cohort study
Schoenau J; Wester A; Schattenberg JM; Hagstrom H
Article: THE LANCET GASTROENTEROLOGY AND HEPATOLOGY. 2023;8(8):704-713
Performance of non-invasive tests and histology for the prediction of clinical outcomes in patients with non-alcoholic fatty liver disease: an individual participant data meta-analysis
Mozes FE; Lee JA; Vali Y; Alzoubi O; Staufer K; Trauner M; Paternostro R; Stauber RE; Holleboom AG; van Dijk A-M; Mak AL; Boursier J; Loup MDS; Shima T; Bugianesi E; Gaia S; Armandi A; Shalimar; Lupsor-Platon M; Wong VW-S; Li G; Wong GL-H; Cobbold J; Karlas T; Wiegand J; Sebastiani G; Tsochatzis E; Liguori A; Yoneda M; Nakajima A; Hagstrom H; Akbari C; Hirooka M; Chan W-K; Mahadeva S; Rajaram R; Zheng M-H; George J; Eslam M; Petta S; Pennisi G; Vigano M; Ridolfo S; Aithal GP; Palaniyappan N; Lee DH; Ekstedt M; Nasr P; Cassinotto C; de Ledinghen V; Berzigotti A; Mendoza YP; Noureddin M; Truong E; Fournier-Poizat C; Geier A; Martic M; Tuthill T; Anstee QM; Harrison SA; Bossuyt PM; Pavlides M
Article: JOURNAL OF INTERNAL MEDICINE. 2023;294(2):216-227
Increased risk for microvascular outcomes in NAFLD-A nationwide, population-based cohort study
Ebert T; Widman L; Stenvinkel P; Hagstrom H
Article: CLINICAL GASTROENTEROLOGY AND HEPATOLOGY. 2023;21(7):1841-1853.e12
Cardiovascular Outcomes in Patients With Biopsy-proven Alcohol-related Liver Disease
Hagstrom H; Thiele M; Sharma R; Simon TG; Roelstraete B; Soderling J; Sundstrom J; Ludvigsson JF
Journal article: JOURNAL OF HEPATOLOGY. 2023;78:s682
Screening for advanced fibrosis due to NAFLD in patients with type 2 diabetes in a retina scanning facility
Lindfors A; Strandberg R; Hagstrom H
Journal article: JOURNAL OF HEPATOLOGY. 2023;78:s651-s652
Novel artificial intelligence-assisted digital pathology quantitative image analysis predicts the occurrence of liver-related clinical events in the multicentric, European, hepatic outcomes and survival fatty liver registry (HOTSURFR) study
Chen L; Petitjean L; Ampuero J; Boursier J; Kechagias S; Petta S; Hagstrom H; Schattenberg J; Charlotte F; Kara L; Bedossa P; Petitjean M; Ratziu V
Journal article: JOURNAL OF HEPATOLOGY. 2023;78:s607
Histological classifications versus liver-related events: results from the multicentric, European, hepatic outcomes and survival fatty liver registry (HOTSURFR) study
Ratziu V; Ampuero J; Boursier J; Kechagias S; Petta S; Hagstrom H; Schattenberg J; Belin L; Cyrille S; Charlotte F; Kara L; Bedossa P
Journal article: JOURNAL OF HEPATOLOGY. 2023;78:s159-s160
Disentangling the contributions of alcohol and alcohol-related liver disease towards dementia
Zhao S; Widman L; Hagstrom H; Shang Y
Journal article: JOURNAL OF HEPATOLOGY. 2023;78:s157-s158
Diabetes increases risk of mortality in alcohol-related liver disease
Theodoreson M; Aithal G; Allison M; Brahmania M; Forrest E; Hagstrom H; Likhitsup A; Masson S; McCune A; Rajoriya N; Rowe I; Parker R
Journal article: JOURNAL OF HEPATOLOGY. 2023;78:s653
Predicting severe liver outcomes in NAFLD using repeated measurements of biomarkers-a cohort study in 1,260 patients
Shang Y; Akbari C; Dodd M; Zhang X; Wang T; Jemielita T; Fernandes G; Engel S; Nasr P; Vessby J; Rorsman F; Kechagias S; Stal P; Ekstedt M; Hagstrom H
Journal article: JOURNAL OF HEPATOLOGY. 2023;78:s654
SAT-399 Prevalence of NAFLD and advanced fibrosis in Stockholm, Sweden
Grip ET; Skröder H; Shang Y; Ström O; Hagström H
Journal article: JOURNAL OF HEPATOLOGY. 2023;78:s707
Performance of novel collagen turnover biomarkers in relation to FIB-4 to detect advanced fibrosis in NAFLD
Hegmar H; Moller T; Nasr P; Vessby J; Kechagias S; Nyhlin N; Marschall H-U; Borssen AD; Karsdal M; Leeming D; Ekstedt M; Hagstrom H
Article: NUTRITION. 2023;110:111982
Macronutrient composition and its effect on body composition changes during weight loss therapy in patients with non-alcoholic fatty liver disease: Secondary analysis of a randomized controlled trial
Lindqvist C; Holmer M; Hagstrom H; Petersson S; Tillander V; Brismar TB; Stal P
Journal article: JOURNAL OF HEPATOLOGY. 2023;78:s959-s960
Four-fold increased mortality rate in patients with Wilson's disease: a population-based cohort study of 151 patients
Aberg F; Shang Y; Strandberg R; Wester A; Widman L; Hagstrom H
Journal article: JOURNAL OF HEPATOLOGY. 2023;78:s302-s303
Secondary prevention of variceal bleeding is often imperfect: a national, population-based cohort study of 5,018 patients
Hagstrom H; Shang Y; Tapper E; Wester A; Widman L
Journal article: JOURNAL OF HEPATOLOGY. 2023;78:s276
Six-fold increased rate of chronic kidney disease after acute kidney injury: a population-based cohort study of 46,946 patients with cirrhosis
Cederborg A; Widman L; Haraldsson B; Lindkvist B; Shang Y; Wester A; Hagstrom H; Marschall H-U
Journal article: JOURNAL OF HEPATOLOGY. 2023;78:s960
Risk of cirrhosis and hepatocellular carcinoma in hemochromatosis: a Swedish nationwide cohort study
Astrom H; Wester A; Widman L; Stal P; Hagstrom H
Journal article: JOURNAL OF HEPATOLOGY. 2023;78:s121
A new risk model outperforms FIB-4 when predicting incident cirrhosis in the general population: a cohort study of 504,000 persons
Strandberg R; Talback M; Hammar N; Hagstrom H
Journal article: JOURNAL OF HEPATOLOGY. 2023;78:s857
SAT-115 Healthcare resource use and costs among patients with primary sclerosing cholangitis in Sweden-a retrospective population-based cohort study
Bergquist A; Kachru N; Aldvén M; Ström O; Knutsson D; Grip ET; Hagström H
Journal article: JOURNAL OF HEPATOLOGY. 2023;78:s46
Risk of cancer and subsequent mortality in primary biliary cholangitis: a population-based cohort study of 3,052 patients
Wester A; Schoenau J; Schattenberg J; Hagstrom H
Journal article: JOURNAL OF HEPATOLOGY. 2023;78:s600
Risk of bacterial infections in non-alcoholic fatty liver disease: a nationwide population-based cohort study
Wester A; Shang Y; Widman L; Ebrahimi F
Journal article: JOURNAL OF HEPATOLOGY. 2023;78:s88-s89
Inreased risk of hepatocellular carcinoma among first-degree relatives of patients with biopsy-proven NAFLD - a multigenerational nationwide cohort study
Ebrahimi F; Simon T; Hagstrom H; Sun J; Bergman D; Roelstraete B; Ludvigsson J
Journal article: JOURNAL OF HEPATOLOGY. 2023;78:s605
Causes of death by fibrosis stage in 959 biopsy-proven NAFLD patients
Shang Y; Akbari C; Dodd M; Nasr P; Vessby J; Rorsman F; Kechagias S; Stal P; Ekstedt M; Hagstrom H
Journal article: JOURNAL OF HEPATOLOGY. 2023;78:s650-s651
Long-term liver-related outcomes in 1,260 patients with non-cirrhotic NAFLD
Akbari C; Dodd M; Zhang X; Wang T; Jemielita T; Fernandes G; Engel S; Nasr P; Vessby J; Rorsman F; Kechagias S; Stal P; Ekstedt M; Hagstrom H; Shang Y
Journal article: GASTROENTEROLOGY. 2023;164(6):s-1037
Tu1376 RISK OF HEPATITIS B INFECTION IN PEOPLE WITH CELIAC DISEASE; A POPULATION-BASED STUDY
Jossen J; Lebwohl B; Soderling J; Duberg A-S; Aleman S; Sharma R; Hagstrom H; Green PH; Ludvigsson JF
Article: CLINICAL GASTROENTEROLOGY AND HEPATOLOGY. 2023;21(5):1271-1280.e7
Risk of Fractures and Subsequent Mortality in Alcohol-Related Cirrhosis: A Nationwide Population-Based Cohort Study
Wester A; Ndegwa N; Hagstrom H
Article: NATURE REVIEWS ENDOCRINOLOGY. 2023;19(5):299-310
Consensus Statement on the definition and classification of metabolic hyperferritinaemia
Valenti L; Corradini E; Adams LA; Aigner E; Alqahtani S; Arrese M; Bardou-Jacquet E; Bugianesi E; Fernandez-Real J-M; Girelli D; Hagstrom H; Henninger B; Kowdley K; Ligabue G; McClain D; Laine F; Miyanishi K; Muckenthaler MU; Pagani A; Pedrotti P; Pietrangelo A; Prati D; Ryan JD; Silvestri L; Spearman CW; Stal P; Tsochatzis EA; Vinchi F; Zheng M-H; Zoller H
Article: CLINICAL GASTROENTEROLOGY AND HEPATOLOGY. 2023;21(4):995-1004.e9
Three-fold Increased Risk of Death in Budd-Chiari Syndrome Compared to Matched Controls: A Population-based Cohort Study
aberg F; Rajani R; Wester A; Widman L; Hagstrom H
Article: NATURE. 2023;615(7950):134-142
FXR inhibition may protect from SARS-CoV-2 infection by reducing ACE2
Brevini T; Maes M; Webb GJ; John BV; Fuchs CD; Buescher G; Wang L; Griffiths C; Brown ML; Scott WEIII; Pereyra-Gerber P; Gelson WTH; Brown S; Dillon S; Muraro D; Sharp J; Neary M; Box H; Tatham L; Stewart J; Curley P; Pertinez H; Forrest S; Mlcochova P; Varankar SS; Darvish-Damavandi M; Mulcahy VL; Kuc RE; Williams TL; Heslop JA; Rossetti D; Tysoe OC; Galanakis V; Vila-Gonzalez M; Crozier TWM; Bargehr J; Sinha S; Upponi SS; Fear C; Swift L; Saeb-Parsy K; Davies SE; Wester A; Hagstrom H; Melum E; Clements D; Humphreys P; Herriott J; Kijak E; Cox H; Bramwell C; Valentijn A; Illingworth CJR; Dahman B; Bastaich DR; Ferreira RD; Marjot T; Barnes E; Moon AM; Barritt AS; Gupta RK; Baker S; Davenport AP; Corbett G; Gorgoulis VG; Buczacki SJA; Lee J-H; Matheson NJ; Trauner M; Fisher AJ; Gibbs P; Butler AJ; Watson CJE; Mells GF; Dougan G; Owen A; Lohse AW; Vallier L; Sampaziotis F
Article: NUTRITION JOURNAL. 2023;22(1):14
Low carbohydrate high fat-diet in real life assessed by diet history interviews
Hagstrom H; Hagfors LN; Tellstrom A; Hedelin R; Lindmark K
Article: JOURNAL OF INHERITED METABOLIC DISEASE. 2023;46(2):286-299
Risk for incident comorbidities, nonhepatic cancer and mortality in acute hepatic porphyria: A matched cohort study in 1244 individuals
Lissing M; Vassiliou D; Floderus Y; Harper P; Yan J; Hagstrom H; Sardh E; Wahlin S
Article: GUT. 2023;72(3):573-580
Cardiovascular disease risk in paediatric and young adult non-alcoholic fatty liver disease
Simon TG; Roelstraete B; Alkhouri N; Hagstrom H; Sundstrom J; Ludvigsson JF
Article: AMERICAN HEART JOURNAL. 2023;257:33-40
Rationale and design of BROKEN-SWEDEHEART: a registry-based, randomized, parallel, open-label multicenter trial to test pharmacological treatments for broken heart (takotsubo) syndrome
Omerovic E; James S; Erlinge D; Hagstrom H; Venetsanos D; Henareh L; Ekenback C; Alfredsson J; Hambreus K; Redfors B
Article: UNITED EUROPEAN GASTROENTEROLOGY JOURNAL. 2023;11(1):79-91
Post-pancreatitis diabetes mellitus is common in chronic pancreatitis and is associated with adverse outcomes
Dugic A; Hagstrom H; Dahlman I; Rutkowski W; Daou D; Kulinski P; Lohr J-M; Vujasinovic M
Article: HEPATOLOGY COMMUNICATIONS. 2023;7(2):e0015
Autopsy histology data suggest cirrhosis is frequently under-reported on death certificates
Hagstrom H; Simon TG; Soderling J; Ludvigsson JF
Article: JOURNAL OF INTERNAL MEDICINE. 2023;293(2):184-199
Unrecognized liver cirrhosis is common and associated with worse survival in hepatocellular carcinoma: A nationwide cohort study of 3473 patients
Vaz J; Stromberg U; Midlov P; Eriksson B; Buchebner D; Hagstrom H
Article: ALIMENTARY PHARMACOLOGY AND THERAPEUTICS. 2023;57(4):418-425
Improved prediction of 10-year risk of severe liver disease in the general population using commonly available biomarkers
Hagstrom H; Yan J; Talback M; Andreasson A; Walldius G; Bottai M; Hammar N
Article: JHEP REPORTS. 2023;5(1):100596
Real-world evidence on non-invasive tests and associated cut-offs used to assess fibrosis in routine clinical practice
Lazarus JV; Castera L; Mark HE; Allen AM; Adams LA; Anstee QM; Arrese M; Alqahtani SA; Bugianesi E; Colombo M; Cusi K; Hagstrom H; Loomba R; Romero-Gomez M; Schattenberg JM; Thiele M; Valenti L; Wong VW-S; Yilmaz Y; Younossi ZM; Francque SM; Tsochatzis EA
Article: CLINICAL GASTROENTEROLOGY AND HEPATOLOGY. 2023;21(1):103-114.e10
Pregnancy Outcomes in Women With Autoimmune Hepatitis - A Nationwide Population-based Cohort Study With Histopathology
Sharma R; Simon TG; Stephansson O; Verna EC; Emond J; Soderling J; Roelstraete B; Hagstrom H; Ludvigsson JF
Article: GASTRO HEP ADVANCES. 2023;2(7):879-888
Risk of Cancer and Subsequent Mortality in Primary Biliary Cholangitis: A Population-based Cohort Study of 3052 Patients.
Schönau J; Wester A; Schattenberg JM; Hagström H
Journal article: CLINICAL EPIDEMIOLOGY. 2023;15:753
Adaptation of the Charlson Comorbidity Index for Register-Based Research in Sweden (vol 13, pg 21, 2021)
Ludvigsson JF; Appelros P; Askling J
Article: FRONTIERS IN IMMUNOLOGY. 2023;14:1186097
Dysregulated peripheral proteome reveals NASH-specific signatures identifying patient subgroups with distinct liver biology
Stiglund N; Hagstrom H; Stal P; Cornillet M; Bjorkstrom NK
Article: LIVER INTERNATIONAL. 2022;42(12):2769-2780
Effect of common genetic variants on the risk of cirrhosis in non-alcoholic fatty liver disease during 20 years of follow-up
Holmer M; Ekstedt M; Nasr P; Zenlander R; Wester A; Tavaglione F; Romeo S; Kechagias S; Stal P; Hagstrom H
Article: SCIENTIFIC REPORTS. 2022;12(1):20519
Associations between subcutaneous adipocyte hypertrophy and nonalcoholic fatty liver disease
Holmer M; Hagstrom H; Chen P; Danielsson O; Aouadi M; Ryden M; Stal P
Article: HEPATOLOGY. 2022;76(5):1495-1505
Risk of cardiovascular disease and loss in life expectancy in NAFLD
Shang Y; Nasr P; Widman L; Hagstrom H
Article: SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY. 2022;57(9):1080-1088
Hepatocellular carcinoma in Stockholm, Sweden 2003-2018: a population-based cohort study
Noren S; Bengtsson B; Hagstrom H; Ljunggren G; Wahlin S
Article: JOURNAL OF INTERNAL MEDICINE. 2022;292(3):492-500
Risk of fractures and subsequent mortality in non-alcoholic fatty liver disease: A nationwide population-based cohort study
Wester A; Hagstrom H
Article: GUT. 2022;71(9):1867-1875
Non-alcoholic fatty liver disease and incident major adverse cardiovascular events: results from a nationwide histology cohort
Simon TG; Roelstraete B; Hagstrom H; Sundstroem J; Ludvigsson JF
Article: NEUROLOGY. 2022;99(6):e574-e582
Nonalcoholic Fatty Liver Disease and Risk of Dementia A Population-Based Cohort Study
Shang Y; Widman L; Hagstrom H
Article: SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY. 2022;57(8):978-983
Cohort profile: decoding the epidemiology of liver disease in Sweden (DELIVER)
Hagstrom H; Shang Y; Wester A; Widman L
Journal article: JOURNAL OF HEPATOLOGY. 2022;77:s82
OS112 Incidence, prevalence and mortality of chronic liver diseases in Sweden between 2005 and 2019
Nasr P; Ndegwa N; von Seth E; Ludvigsson J; Hagström H
Journal article: JOURNAL OF HEPATOLOGY. 2022;77:s189
THU179 MAIT-cells in blood are associated with a higher risk of infection in patients with cirrhosis
Bengtsson B; Maucourant C; Shang Y; Sandberg JK; Björkström N; Hagström H
Journal article: JOURNAL OF HEPATOLOGY. 2022;77:s141
THU041 Refining the natural history of alcohol related liver disease: a competing risk analysis
Parker R; Aithal G; Allison M; Arab JP; Brahmania M; Forrest E; Hagström H; Likhitsup A; Masson S; McCune A; Rajoriya N; Rowe I
Journal article: JOURNAL OF HEPATOLOGY. 2022;77:s413
FRI035 Health outcomes and risk assessment in chronic liver disease (HERALD): a large Swedish research platform
Grip ET; Ström O; Hagström H
Journal article: JOURNAL OF HEPATOLOGY. 2022;77:s30
OS026 Liver stiffness predicts incident severe liver disease in patients with chronic liver disease
Hegmar H; Wester A; Aleman S; Backman J; Degerman E; Ekvall H; Lund K; Lundgren Å; Nasr P; Shahnavaz A; Vessby J; Westin J; Önnerhag K; Hagström H
Journal article: JOURNAL OF HEPATOLOGY. 2022;77:s123
THU010 Risk of fractures and subsequent mortality in alcohol-related cirrhosis: a nationwide population-based cohort study
Wester A; Ndegwa N; Hagström H
Journal article: JOURNAL OF HEPATOLOGY. 2022;77:s119-s120
THU002 Biomarkers for prediction of alcohol-related liver cirrhosis in the Swedish general population
Jakobsson G; Talbäck M; Walldius G; Hammar N; Shang Y; Hagström H
Journal article: JOURNAL OF HEPATOLOGY. 2022;77:s24
OS016 Prediction of ten-year risk of severe liver disease in the general population using commonly available biomarkers
Hagström H; Yan J; Talbäck M; Andreasson A; Walldius G; Bottai M; Hammar N
Journal article: JOURNAL OF HEPATOLOGY. 2022;77:s530
FRI275 Cancer risk in acute hepatic porphyria: a nationwide matched cohort study in 1, 245 individuals
Lissing M; Vassiliou D; Floderus Y; Yan J; Hagström H; Sardh E; Wahlin S
Journal article: JOURNAL OF HEPATOLOGY. 2022;77:s423
FRI053 The PNPLA3 (rs738409) G/G-genotype is associated with presence of NASH and increased long-term risk of cirrhosis in NAFLD
Holmer M; Zenlander R; Wester A; Ekstedt M; Nasr P; Kechagias S; Romeo S; Stal P; Hagström H
Article: JOURNAL OF INTERNAL MEDICINE. 2022;291(6):824-836
Risk of primary liver cancer in acute hepatic porphyria patients: A matched cohort study of 1244 individuals
Lissing M; Vassiliou D; Floderus Y; Harper P; Bottai M; Kotopouli M; Hagstrom H; Sardh E; Wahlin S
Article: UNITED EUROPEAN GASTROENTEROLOGY JOURNAL. 2022;10(5):465-476
The risk of hepatocellular carcinoma in cirrhosis differs by etiology, age and sex: A Swedish nationwide population-based cohort study
Bengtsson B; Widman L; Wahlin S; Stal P; Bjorkstrom NK; Hagstrom H
Article: ESC HEART FAILURE. 2022;9(3):1812-1822
Temporal trends in characteristics and outcome of heart failure patient with and without signification coronary artery disease
Bollano E; Redfors B; Rawshani A; Venetsanos D; Volz S; Angeras O; Ljungman C; Alfredsson J; Jernberg T; Ramunddal T; Petursson P; Smith JG; Braun O; Hagstrom H; Frobert O; Erlinge D; Omerovic E
Journal article: GASTROENTEROLOGY. 2022;162(7):s-1270-s-1271
Tu1310: NON-INVASIVE TESTS (NITS) FOR PREDICTING HEPATOCELLULAR CARCINOMA IN NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) PATIENTS WITHOUT CIRRHOSIS: A SYSTEMATIC REVIEW AND META-ANALYSIS OF INDIVIDUAL PATIENT DATA AND AGGREGATE DATA
Siriwong N; Sriphoosanaphan S; Yongpisarn T; Apiparakoon T; Tiyarattanachai T; Kerr SJ; Treeprasertsuk S; Hagstrom H; Akbari C; Ekstedt M; Ito T; Ishigami M; Toyoda H; Hino K; Kawanaka M; sumida Y; Seko Y; Peleg N; Shlomai A; Yip TCF; Wong GL; Chaiteerakij R
Article: JOURNAL OF HEPATOLOGY. 2022;76(5):1013-1020
Non-invasive tests accurately stratify patients with NAFLD based on their risk of liver-related events
Boursier J; Hagstrom H; Ekstedt M; Moreau C; Bonacci M; Cure S; Ampuero J; Nasr P; Tallab L; Canivet CM; Kechagias S; Sanchez Y; Dincuff E; Lucena A; Roux M; Riou J; Trylesinski A; Romero-Gomez M
Article: JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM (JCEM). 2022;107(5):e2008-e2020
Obesity Modifies the Performance of Fibrosis Biomarkers in Nonalcoholic Fatty Liver Disease
Qadri S; Ahlholm N; Lonsmann I; Pellegrini P; Poikola A; Luukkonen PK; Porthan K; Juuti A; Sammalkorpi H; Penttila AK; D'Ambrosio R; Soardo G; Leeming DJ; Karsdal M; Arola J; Kechagias S; Pelusi S; Ekstedt M; Valenti L; Hagstrom H; Yki-Jarvinen H
Article: LIVER INTERNATIONAL. 2022;42(4):820-828
Risk of hepatic and extrahepatic cancer in NAFLD: A population-based cohort study
Bjorkstrom K; Widman L; Hagstrom H
Article: CLINICAL GASTROENTEROLOGY AND HEPATOLOGY. 2022;20(4):918-929.e8
Risk of Cancer in Biopsy-Proven Alcohol-Related Liver Disease: A Population-Based Cohort Study of 3410 Persons
Hagstrom H; Thiele M; Sharma R; Simon TG; Roelstraete B; Soderling J; Ludvigsson JF
Article: UNITED EUROPEAN GASTROENTEROLOGY JOURNAL. 2022;10(2):198-211
Risk of infections and their role on subsequent mortality in biopsy-proven alcohol-related liver disease
Hagstrom H; Thiele M; Simon TG; Sharma R; Rockert Tjernberg A; Roelstraete B; Soderling J; Ludvigsson JF
Journal article: JOURNAL OF THE CANADIAN ASSOCIATION OF GASTROENTEROLOGY. 2022;5(Supplement_1):89-90
A203 INCIDENCE AND PREDICTORS OF NON-HEPATIC CANCERS IN ALCOHOL RELATED LIVER DISEASE IN THE WALDO COHORT
Hindi Z; Brahmania M; Arab J; Shi N; Rajoriya N; Aithal G; Allison M; Hagström H; Likhitsup A; McCune A; Masson S; Parker R
Article: AMERICAN JOURNAL OF EPIDEMIOLOGY. 2022;191(2):298-319
Cancer Risk in Patients With Autoimmune Hepatitis: A Nationwide Population-Based Cohort Study With Histopathology
Sharma R; Verna EC; Simon TG; Soderling J; Hagstrom H; Green PHR; Ludvigsson JF
Article: ALIMENTARY PHARMACOLOGY AND THERAPEUTICS. 2022;55(2):234-243
A sustainable development goal framework to guide multisectoral action on NAFLD through a societal approach
Lazarus JV; Mark HE; Colombo M; Demaio S; Dillon JF; George J; Hagstroem H; Hocking S; Lee N; Nieuwenhuijsen MJ; Rinella ME; Romero-Gomez M; Soriano JB; Schattenberg JM; Tacke F; Tsochatzis EA; Valenti L; Zelber-Sagi S; Dirac MA; Huang TT-K
Article: NATURE REVIEWS GASTROENTEROLOGY AND HEPATOLOGY. 2022;19(1):60-78
Advancing the global public health agenda for NAFLD: a consensus statement
Lazarus JV; Mark HE; Anstee QM; Arab JP; Batterham RL; Castera L; Cortez-Pinto H; Crespo J; Cusi K; Dirac MA; Francque S; George J; Hagstrom H; Huang TT-K; Ismail MH; Kautz A; Sarin SK; Loomba R; Miller V; Newsome PN; Ninburg M; Ocama P; Ratziu V; Rinella M; Romero D; Romero-Gomez M; Schattenberg JM; Tsochatzis EA; Valenti L; Wong VW-S; Yilmaz Y; Younossi ZM; Zelber-Sagi S
Article: CLINICAL GASTROENTEROLOGY AND HEPATOLOGY. 2021;19(12):2636-2647.e13
Increased Mortality Risk in Autoimmune Hepatitis: A Nationwide Population-Based Cohort Study With Histopathology
Sharma R; Verna EC; Soderling J; Roelstraete B; Hagstrom H; Ludvigsson JF
Article: BMC GASTROENTEROLOGY. 2021;21(1):439
Risk of severe COVID-19 and mortality in patients with established chronic liver disease: a nationwide matched cohort study
Simon TG; Hagstrom H; Sharma R; Soderling J; Roelstraete B; Larsson E; Ludvigsson JF
Article: JOURNAL OF HEPATOLOGY. 2021;75(5):1042-1048
Maternal obesity increases the risk and severity of NAFLD in offspring
Hagstrom H; Simon TG; Roelstraete B; Stephansson O; Soderling J; Ludvigsson JF
Article: HEPATOLOGY. 2021;74(5):2410-2423
Cancer Risk in Patients With Biopsy-Confirmed Nonalcoholic Fatty Liver Disease: A Population-Based Cohort Study
Simon TG; Roelstraete B; Sharma R; Khalili H; Hagstrom H; Ludvigsson JF
Article: EUROPEAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY. 2021;33(11):1420-1426
A personalized treatment program in persons with type 2 diabetes is associated with a reduction in liver steatosis
Bjorkstrom K; Stal P; Holmer M; Bengtsson B; Staaf A; Hoffstedt J; Hagstrom H
Article: JHEP REPORTS. 2021;3(5):100343
External validation of the Toronto hepatocellular carcinoma risk index in a Swedish population
Astrom H; Ndegwa N; Hagstrom H
Article: NATURE REVIEWS GASTROENTEROLOGY AND HEPATOLOGY. 2021;18(10):717-729
Defining comprehensive models of care for NAFLD
Lazarus JV; Anstee QM; Hagstrom H; Cusi K; Cortez-Pinto H; Mark HE; Roden M; Tsochatzis EA; Wong VW-S; Younossi ZM; Zelber-Sagi S; Romero-Gomez M; Schattenberg JM
Article: JOURNAL OF CLINICAL MEDICINE. 2021;10(16):3720
Vascular Complications in Patients with Chronic Pancreatitis
Vujasinovic M; Dugic A; Nouri A; Brismar TB; Baldaque-Silva F; Asplund E; Rutkowski W; Ghorbani P; Sparrelid E; Hagstrom H; Lohr J-M
Article: NUTRIENTS. 2021;13(7):2386
Low Bone Mineral Density and Risk for Osteoporotic Fractures in Patients with Chronic Pancreatitis
Vujasinovic M; Nezirevic Dobrijevic L; Asplund E; Rutkowski W; Dugic A; Kahn M; Dahlman I; Saaf M; Hagstrom H; Lohr J-M
Article: JOURNAL OF HEPATOLOGY. 2021;75(1):98-107
A pilot study of golexanolone, a new GABA-A receptor-modulating steroid antagonist, in patients with covert hepatic encephalopathy
Montagnese S; Lauridsen M; Vilstrup H; Zarantonello L; Lakner G; Fitilev S; Zupanets I; Kozlova I; Bunkova E; Tomasiewicz K; Berglund JE; Rorsman F; Hagstrom H; Kechagias S; Ocklind CE; Mauney J; Thunarf F; Mokhatarani M; Backstrom T; Doverskog M; Lins L-E; Mansson M; Samuelson P; Nilsson D; Schalling M; Johansson M; Arlander E; Scharschmidt BF
Article: HEPATOLOGY. 2021;74(1):474-482
Administrative Coding in Electronic Health Care Record-Based Research of NAFLD: An Expert Panel Consensus Statement
Hagstrom H; Adams LA; Allen AM; Byrne CD; Chang Y; Gronbaek H; Ismail M; Jepsen P; Kanwal F; Kramer J; Lazarus JV; Long MT; Loomba R; Newsome PN; Rowe IA; Ryu S; Schattenberg JM; Serper M; Sheron N; Simon TG; Tapper EB; Wild S; Wong VW-S; Yilmaz Y; Zelber-Sagi S; Aberg F
Article: GUT. 2021;70(7):1375-1382
Mortality in biopsy-confirmed nonalcoholic fatty liver disease: results from a nationwide cohort
Simon TG; Roelstraete B; Khalili H; Hagstrom H; Ludvigsson JF
Article: SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY. 2021;56(6):727-732
Etiologies and outcomes of cirrhosis in a large contemporary cohort
Hagstrom H; Lindfors A; Holmer M; Bengtsson B; Bjorkstrom K; Hegmar H; von Seth E
Article: JHEP REPORTS. 2021;3(3):100256
Treatment of NAFLD with intermittent calorie restriction or low-carb high-fat diet - a randomised controlled trial
Holmer M; Lindqvist C; Petersson S; Moshtaghi-Svensson J; Tillander V; Brismar TB; Hagstrom H; Stal P
Article: HEPATOLOGY COMMUNICATIONS. 2021;5(6):1021-1035
A Dynamic Aspartate-to-Alanine Aminotransferase Ratio Provides Valid Predictions of Incident Severe Liver Disease
Aberg F; Danford CJ; Thiele M; Talback M; Rasmussen DN; Jiang ZG; Hammar N; Nasr P; Ekstedt M; But A; Puukka P; Krag A; Sundvall J; Erlund I; Salomaa V; Stal P; Kechagias S; Hultcrantz R; Lai M; Afdhal N; Jula A; Mannisto S; Lundqvist A; Perola M; Farkkila M; Hagstrom H
Article: ENDOSCOPY INTERNATIONAL OPEN. 2021;09(05):E727-E734
Wide-field endoscopic submucosal dissection for the treatment of Barrett's esophagus neoplasia
Omae M; Hagstrom H; Ndegwa N; Vieth M; Wang N; Vujasinovic M; Baldaque-Silva F
Article: SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY. 2021;56(4):437-442
Serum levels of endotrophin are associated with nonalcoholic steatohepatitis
Hagstrom H; Bu D; Nasr P; Ekstedt M; Hegmar H; Kechagias S; Zhang N; An Z; Stal P; Scherer PE
Article: JHEP REPORTS. 2021;3(2):100218
Non-alcoholic fatty liver disease does not increase dementia risk although histology data might improve risk prediction
Shang Y; Nasr P; Ekstedt M; Widman L; Stal P; Hultcrantz R; Kechagias S; Hagstrom H
Article: LIVER INTERNATIONAL. 2021;41(3):545-553
Morbidity, risk of cancer and mortality in 3645 HFE mutations carriers
Hagstrom H; Ndegwa N; Jalmeus M; Ekstedt M; Posserud I; Rorsman F; Nyhlin N; Klintman D; Werner M; Marschall H-U; Askling J; Stal P
Article: CLINICAL EPIDEMIOLOGY. 2021;13:21-41
Adaptation of the Charlson Comorbidity Index for Register-Based Research in Sweden
Ludvigsson JF; Appelros P; Askling J; Byberg L; Carrero J-J; Ekstrom AM; Ekstrom M; Smedby KE; Hagstrom H; James S; Jarvholm B; Michaelsson K; Pedersen NL; Sundelin H; Sundquist K; Sundstrom J
Article: GUT. 2021;70(1):170-179
Mortality in biopsy-proven alcohol-related liver disease: a population-based nationwide cohort study of 3453 patients
Hagstrom H; Thiele M; Roelstraete B; Soderling J; Ludvigsson JF
Article: JOURNAL OF CLINICAL MEDICINE. 2020;9(11):E3720-3720
Risk of Developing Pancreatic Cancer in Patients with Chronic Pancreatitis
Vujasinovic M; Dugic A; Maisonneuve P; Aljic A; Berggren R; Panic N; Valente R; Pozzi Mucelli R; Waldthaler A; Ghorbani P; Kordes M; Hagstrom H; Lohr J-M
Article: JOURNAL OF HEPATOLOGY. 2020;73(5):1023-1029
Repeated FIB-4 measurements can help identify individuals at risk of severe liver disease
Hagstrom H; Talback M; Andreasson A; Walldius G; Hammar N
Article: THE LANCET GASTROENTEROLOGY AND HEPATOLOGY. 2020;5(11):1008-1016
Outcomes following SARS-CoV-2 infection in liver transplant recipients: an international registry study
Webb GJ; Marjot T; Cook JA; Aloman C; Armstrong MJ; Brenner EJ; Catana M-A; Cargill T; Dhanasekaran R; Garcia-Juarez I; Hagstrom H; Kennedy JM; Marshall A; Masson S; Mercer CJ; Perumalswami PV; Ruiz I; Thaker S; Ufere NN; Barnes E; Barritt AS; Moon AM
Article: SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY. 2020;55(10):1205-1210
Validity of administrative codes associated with cirrhosis in Sweden
Bengtsson B; Askling J; Ludvigsson JF; Hagstrom H
Journal article: JOURNAL OF HEPATOLOGY. 2020;73:s178
THU077 Mortality in biopsy-proven alcohol-related liver disease: population-based cohort study of 3,453 individuals
Hagström H; Thiele M; Roelstraete B; Söderling J; Ludvigsson JF
Journal article: JOURNAL OF HEPATOLOGY. 2020;73:s371-s372
THU466 Long-term risk of HCC in persons with cirrhosis: national, population-based cohort study of 7,322 individuals
Bengtsson B; Widman L; Wahlin S; Stal P; Björkström N; Hagström H
Journal article: JOURNAL OF HEPATOLOGY. 2020;73:s63
AS086 Primary liver cancer in acute hepatic porphyria: a national cohort study
Lissing M; Vassiliou D; Floderus Y; Harper P; Bottai M; Kotopouli M; Hagström H; Sardh E; Wahlin S
Journal article: JOURNAL OF HEPATOLOGY. 2020;73:s166-s167
THU053 Europe’s largest meta-analysis on the prevalence of non-alcoholic fatty liver disease, non-alcoholic steatohepatitis and advanced fibrosis (F3-F4)
Petta S; Hagström H; Geier A; Ratziu V; Caballeria L; Expósito C; Hernández R; Blokzijl H; De Knegt R; Ferrinho D; Ntalla I; Smith A; Ramroth H; Newsome PN
Journal article: JOURNAL OF HEPATOLOGY. 2020;73:s128-s129
LBP10 Bariatric surgery is not associated with a reduction in risk of severe liver disease in comparison to standard obesity treatment in 3,922 subjects
Hagström H; Ekstedt M; Olbers T; Peltonen M; Carlsson L
Journal article: JOURNAL OF HEPATOLOGY. 2020;73:s108
AS157 Liver disease progression and clinical outcomes in hepatic outcomes and survival fatty liver registry (HOTSURFR) study
Kutala B; Boursier J; Ekstedt M; Hagström H; Pais R; Bugianesi E; George J; Schattenberg JM; Anstee Q; Bedossa P; Ratziu V
Journal article: JOURNAL OF HEPATOLOGY. 2020;73:s541
FRI285 Prognosis in persons with an HFE-mutation: population-based cohort study of 3,645 individuals
Hagström H; Ndegwa N; Ekstedt M; Posserud I; Rorsman F; Nyhlin N; Klintman D; Werner M; Marschall H-U; Askling J; Stal P
Journal article: JOURNAL OF HEPATOLOGY. 2020;73:s420
FRI040 Macrophage markers do not add to the prediction of liver fibrosis by transient elastography in patients with non-alcoholic fatty liver disease
Kazankov K; Rosso C; Younes R; Hagström H; Møller HJ; Stal P; Bugianesi E; Grønbæk H
Journal article: JOURNAL OF HEPATOLOGY. 2020;73:s70-s71
AS096 Repeated measures of FIB-4 improve prediction of severe liver disease: population-based cohort study of 40,729 individuals
Hagström H; Talbäck M; Andreasson A; Walldius G; Hammar N
Article: CLINICAL GASTROENTEROLOGY AND HEPATOLOGY. 2020;18(7):1592-1599.e8
Health Care Costs of Patients With Biopsy-Confirmed Nonalcoholic Fatty Liver Disease Are Nearly Twice Those of Matched Controls
Hagstrom H; Nasr P; Ekstedt M; Hammar U; Widman L; Stal P; Hultcrantz R; Kechagias S; Henriksson M
Journal article: GASTROENTEROLOGY. 2020;158(6):s-1285-s-1286
690 MORTALITY RISK IN BIOPSY-VERIFIED AUTOIMMUNE HEPATITIS: A NATIONWIDE POPULATION-BASED COHORT STUDY
Sharma R; Verna EC; Soderling J; Roelstraete B; Hagstrom H; Ludvigsson JF
Article: EUROPEAN HEART JOURNAL: CASE REPORTS. 2020;4(1):1-6
Lomitapide treatment in a female with homozygous familial hypercholesterolaemia: a case report
Littmann K; Szummer K; Hagstrom H; Dolapcsiev K; Brinck J; Eriksson M
Article: CLINICAL EPIDEMIOLOGY. 2020;12:1433-1442
Incidence of ICD-Based Diagnoses of Alcohol-Related Disorders and Diseases from Swedish Nationwide Registers and Suggestions for Coding
Bergman D; Hagstrom H; Capusan AJ; Marild K; Nyberg F; Sundquist K; Ludvigsson JF
Article: FRONTIERS IN MEDICINE. 2020;7:616212
Macrophage Markers Do Not Add to the Prediction of Liver Fibrosis by Transient Elastography in Patients With Metabolic Associated Fatty Liver Disease
Kazankov K; Rosso C; Younes R; Armandi A; Hagstrom H; Moller HJ; Stal P; Bugianesi E; Gronbaek H
Article: GASTROENTEROLOGY. 2020;158(1):200-214
Ability of Noninvasive Scoring Systems to Identify Individuals in the Population at Risk for Severe Liver Disease
Hagstrom H; Talback M; Andreasson A; Walldius G; Hammar N
Article: CLINICAL GASTROENTEROLOGY AND HEPATOLOGY. 2019;17(13):2769-2775.e4
Risk Factors for Severe Liver Disease in Patients With Type 2 Diabetes
Bjorkstrom K; Franzen S; Eliasson B; Miftaraj M; Gudbjornsdottir S; Trolle-Lagerros Y; Svensson A-M; Hagstrom H
Article: UNITED EUROPEAN GASTROENTEROLOGY JOURNAL. 2019;7(9):1250-1260
The prediction of colorectal cancer using anthropometric measures: A Swedish population-based cohort study with 22 years of follow-up
Andreasson A; Hagstrom H; Skoldberg F; Onnerhag K; Carlsson AC; Schmidt PT; Forsberg AM
Article: ANNALS OF INTERNAL MEDICINE. 2019;171(5):318-327
Lipophilic Statins and Risk for Hepatocellular Carcinoma and Death in Patients With Chronic Viral Hepatitis: Results From a Nationwide Swedish Population
Simon TG; Duberg A-S; Aleman S; Hagstrom H; Nguyen LH; Khalili H; Chung RT; Ludvigsson JF
Article: SCANDINAVIAN JOURNAL OF RHEUMATOLOGY. 2019;48(4):294-299
The use of anthropometric measures in the prediction of incident gout: results from a Swedish community-based cohort study
Wandell P; Andreasson A; Hagstrom H; Kapetanovic MC; Carlsson AC
Article: DIGESTIVE DISEASES AND SCIENCES. 2019;64(7):2014-2023
Risk Behaviors Associated with Alcohol Consumption Predict Future Severe Liver Disease
Hagstrom H; Hemmingsson T; Discacciati A; Andreasson A
Article: SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY. 2019;54(6):761-765
Transient liver elastography in normal pregnancy - a longitudinal cohort study
Stenberg Ribeiro M; Hagstrom H; Stal P; Ajne G
Article: LIVER INTERNATIONAL. 2019;39(6):1098-1108
Characteristics and outcome of hepatocellular carcinoma in patients with NAFLD without cirrhosis
Bengtsson B; Stal P; Wahlin S; Bjorkstrom NK; Hagstrom H
Article: CLINICAL GASTROENTEROLOGY AND HEPATOLOGY. 2019;17(6):1148-1156.e4
Accuracy of Noninvasive Scoring Systems in Assessing Risk of Death and Liver-Related Endpoints in Patients With Nonalcoholic Fatty Liver Disease
Hagstrom H; Nasr P; Ekstedt M; Stal P; Hultcrantz R; Kechagias S
Journal article: JOURNAL OF HEPATOLOGY. 2019;70(1):e766-e767
SAT-297-Prediction of incident severe liver disease in the general population using non-invasive scoring systems
Hagström H; Talbäck M; Andreasson A; Carlsson A; Walldius G; Hammar N
Article: ALIMENTARY PHARMACOLOGY AND THERAPEUTICS. 2019;49(6):789-796
Body mass index in early pregnancy and future risk of severe liver disease: a population-based cohort study
Hagstrom H; Hoijer J; Andreasson A; Bottai M; Johansson K; Ludvigsson JF; Stephansson O
Article: FRONTIERS IN IMMUNOLOGY. 2019;10:1255
Retained NK Cell Phenotype and Functionality in Non-alcoholic Fatty Liver Disease
Stiglund N; Strand K; Cornillet M; Stal P; Thorell A; Zimmer CL; Naslund E; Karlgren S; Nilsson H; Mellgren G; Ferno J; Hagstrom H; Bjorkstrom NK
Article: PLOS ONE. 2019;14(9):e0223312
Association between temperature, sunlight hours and alcohol consumption
Hagstrom H; Widman L; von Seth E
Article: LIVER INTERNATIONAL. 2019;39(1):197-204
Cardiovascular risk factors in non-alcoholic fatty liver disease
Hagstrom H; Nasr P; Ekstedt M; Hammar U; Stal P; Askling J; Hultcrantz R; Kechagias S
Article: LIVER INTERNATIONAL. 2018;38(11):2082-2090
Nonalcoholic fatty liver disease is an increasing indication for liver transplantation in the Nordic countries
Holmer M; Melum E; Isoniemi H; Ericzon B-G; Castedal M; Nordin A; Schultz NA; Rasmussen A; Line P-D; Stal P; Bennet W; Hagstrom H
Article: HEPATOLOGY COMMUNICATIONS. 2018;2(11):1299-1305
Outcomes of Pregnancy in Mothers With Cirrhosis: A National Population-Based Cohort Study of 1.3 Million Pregnancies
Hagstrom H; Hoijer J; Marschall H-U; Williamson C; Heneghan MA; Westbrook RH; Ludvigsson JF; Stephansson O
Article: CLINICAL GASTROENTEROLOGY AND HEPATOLOGY. 2018;16(9):1474-1480.e1
Lifestyle Factors in Late Adolescence Associate With Later Development of Diverticular Disease Requiring Hospitalization
Jarbrink-Sehgal ME; Schmidt PT; Skoldberg F; Hemmingsson T; Hagstrom H; Andreasson A
Article: HEPATOLOGY. 2018;68(2):625-633
Pregnancy outcome in women undergoing liver biopsy during pregnancy: A nationwide population-based cohort study
Ludvigsson JF; Marschall H-U; Hagstrom H; Hoijer J; Stephansson O
Article: GUT. 2018;67(8):1536-1542
High BMI in late adolescence predicts future severe liver disease and hepatocellular carcinoma: a national, population-based cohort study in 1.2 million men
Hagstrom H; Tynelius P; Rasmussen F
Article: GASTROENTEROLOGY RESEARCH AND PRACTICE. 2018;2018:1942648-7
Steatohepatitis Is Not Associated with an Increased Risk for Fibrosis Progression in Nonalcoholic Fatty Liver Disease
Hagstrom H; Elfwen O; Hultcrantz R; Stal P
Article: LIVER INTERNATIONAL. 2018;38(5):885-894
Quality of life as a prognostic factor for survival in hepatocellular carcinoma
Eilard MS; Hagstrom H; Mortensen KE; Wilsgaard T; Vagnildhaug OM; Dajani O; Stal P; Rizell M
Article: DIGESTIVE DISEASES AND SCIENCES. 2018;63(5):1348-1354
Tacrolimus and Mycophenolate Mofetil as Second-Line Therapies for Pediatric Patients with Autoimmune Hepatitis
Efe C; Al Taii H; Ytting H; Aehling N; Bhanji RA; Hagstrom H; Purnak T; Muratori L; Werner M; Muratori P; Klintman D; Schiano TD; Montano-Loza AJ; Berg T; Larsen FS; Alkhouri N; Ozaslan E; Heneghan MA; Yoshida EM; Wahlin S
Journal article: JOURNAL OF HEPATOLOGY. 2018;68:s823
SAT-485 Risk factors for development of severe liver disease in more than 400 000 patients with type 2 diabetes: A population-based cohort study
Björkström K; Franzén S; Eliasson B; Miftaraj M; Gudbjornsdottir S; Trolle-Lagerros Y; Svensson A-M; Hagström H
Article: JOURNAL OF HEPATOLOGY. 2018;68(3):505-510
Alcohol consumption in late adolescence is associated with an increased risk of severe liver disease later in life
Hagstrom H; Hemmingsson T; Discacciati A; Andreasson A
Article: HEPATOLOGY COMMUNICATIONS. 2018;2(1):48-57
Risk for Development of Severe Liver Disease in Lean Patients With Nonalcoholic Fatty Liver Disease: A Long-Term Follow-Up Study
Hagstrom H; Nasr P; Ekstedt M; Hammar U; Stal P; Hultcrantz R; Kechagias S
Article: PLOS ONE. 2018;13(8):e0202651
Body composition measurements and risk of hematological malignancies: A population-based cohort study during 20 years of follow-up
Hagstrom H; Andreasson A; Carlsson AC; Jerkeman M; Carlsten M
Article: SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY. 2017;52(12):1427-1434
IGFBP-1 and IGF-I as markers for advanced fibrosis in NAFLD - a pilot study
Hagstrom H; Stal P; Hultcrantz R; Brismar K; Ansurudeen I
Article: JOURNAL OF HEPATOLOGY. 2017;67(6):1265-1273
Fibrosis stage but not NASH predicts mortality and time to development of severe liver disease in biopsy-proven NAFLD
Hagstrom H; Nasr P; Ekstedt M; Hammar U; Stal P; Hultcrantz R; Kechagias S
Article: CLINICAL GASTROENTEROLOGY AND HEPATOLOGY. 2017;15(12):1950-1956.e1
Efficacy and Safety of Mycophenolate Mofetil and Tacrolimus as Second-line Therapy for Patients With Autoimmune Hepatitis
Efe C; Hagstrom H; Ytting H; Bhanji RA; Muller NF; Wang Q; Purnak T; Muratori L; Werner M; Marschall H-U; Muratori P; Gunsar F; Klintman D; Pares A; Heurgue-Berlot A; Schiano TD; Cengiz M; Tana MM-S; Ma X; Montano-Loza AJ; Berg T; Verma S; Larsen FS; Ozaslan E; Heneghan MA; Yoshida EM; Wahlin S
Journal article: JOURNAL OF HEPATOLOGY. 2017;67(6):1134-1136
Back to Byzance: Querelles byzantines over NASH and fibrosis
Ratziu V
Article: BEST PRACTICE AND RESEARCH: CLINICAL GASTROENTEROLOGY. 2017;31(5):537-543
Alcohol, smoking and the liver disease patient
Hagstrom H
Article: CLINICAL GASTROENTEROLOGY AND HEPATOLOGY. 2017;15(9):1461-1468
Histologic Scores for Fat and Fibrosis Associate With Development of Type 2 Diabetes in Patients With Nonalcoholic Fatty Liver Disease
Bjorkstrom K; Stal P; Hultcrantz R; Hagstrom H
Article: CLINICAL GASTROENTEROLOGY AND HEPATOLOGY. 2017;15(8):1294-1301.e2
Waist/Hip Ratio Better Predicts Development of Severe Liver Disease Within 20 Years Than Body Mass Index: A Population-based Cohort Study
Andreasson A; Carlsson AC; Onnerhag K; Hagstrom H
Article: LAKARTIDNINGEN. 2017;114:EFMD
[New guidelines for NAFLD – a Swedish perspective].
Hagström H; Hoffstedt J; Reynisdottir S
Article: SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY. 2017;52(2):159-165
Low to moderate lifetime alcohol consumption is associated with less advanced stages of fibrosis in non-alcoholic fatty liver disease
Hagstrom H; Nasr P; Ekstedt M; Kechagias S; Onnerhag K; Nilsson E; Rorsman F; Sheikhi R; Marschall H-U; Hultcrantz R; Stal P
Article: SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY. 2017;52(1):87-91
SAF score and mortality in NAFLD after up to 41 years of follow-up
Hagstrom H; Nasr P; Ekstedt M; Kechagias S; Stal P; Bedossa P; Hultcrantz R
Article: LIVER INTERNATIONAL. 2016;36(11):1688-1695
Elevated serum ferritin is associated with increased mortality in non-alcoholic fatty liver disease after 16 years of follow-up
Hagstrom H; Nasr P; Bottai M; Ekstedt M; Kechagias S; Hultcrantz R; Stal P
Article: JOURNAL OF HEPATOLOGY. 2016;65(2):363-368
Overweight in late adolescence predicts development of severe liver disease later in life: A 39 years follow-up study
Hagstrom H; Stal P; Hultcrantz R; Hemmingsson T; Andreasson A
Article: LIVER INTERNATIONAL. 2016;36(2):268-274
Adverse outcomes of pregnancy in women with non-alcoholic fatty liver disease
Hagstrom H; Hoijer J; Ludvigsson JF; Bottai M; Ekbom A; Hultcrantz R; Stephansson O; Stokkeland K
Article: PLOS ONE. 2016;11(12):e0167776
Development of Serum Marker Models to Increase Diagnostic Accuracy of Advanced Fibrosis in Nonalcoholic Fatty Liver Disease: The New LINKI Algorithm Compared with Established Algorithms
Lykiardopoulos B; Hagstrom H; Fredrikson M; Ignatova S; Stal P; Hultcrantz R; Ekstedt M; Kechagias S
Article: HEPATOLOGY. 2015;61(5):1547-1554
Fibrosis Stage Is the Strongest Predictor for Disease-Specific Mortality in NAFLD After Up to 33 Years of Follow-Up
Ekstedt M; Hagstrom H; Nasr P; Fredrikson M; Stal P; Kechagias S; Hultcrantz R
Article: WORLD JOURNAL OF GASTROENTEROLOGY. 2012;18(24):3105-3111
Alcohol consumption in patients with primary sclerosing cholangitis
Hagstrom H; Stal P; Stokkeland K; Bergquist A
Journal article: MOLECULAR HUMAN REPRODUCTION. 1999;5(8):714-719
Cell characteristics and functions of two enriched fractions of human luteal cells during prolonged culture
Fridén BE; Hagström HG; Lindblom B; Sjöblom P; Wallin A; Brännström M; Hahlin M
Journal article: HUMAN REPRODUCTION. 1997;12(Suppl_2):234-235
P-246. Co-culture of human trophoblastic and corpus luteum cells in vitro : a pilot study
Fridén BE; Hagström H-G; Brännström M; Lindblom B; Hahlin M; Sjöblom P
Visa fler

Alla övriga publikationer

Letter: GUT. 2024;73(11):e30
Cause of death by fibrosis stage in 959 patients with biopsy-proven NAFLD
Shang Y; Akbari C; Dodd M; Nasr P; Vessby J; Rorsman F; Kechagias S; Stal P; Ekstedt M; Hagstrom H
Review: JOURNAL OF HEPATOLOGY. 2024;81(1):149-162
Developing and validating clinical prediction models in hepatology - An overview for clinicians
Strandberg R; Jepsen P; Hagstrom H
Letter: CLINICAL GASTROENTEROLOGY AND HEPATOLOGY. 2024;22(3):670
Secondary Prevention of Esophageal Variceal Bleeding: Still a Long Way to Go Reply
Hagstrom H; Shang Y; Tapper EB; Wester A; Widman L
Review: UNITED EUROPEAN GASTROENTEROLOGY JOURNAL. 2024;12(2):168-176
Interactions between the metabolic syndrome and alcohol consumption increases the risk of liver disease
Hagstrom H; Hegmar H; Moreno C
Corrigendum: NATURE REVIEWS ENDOCRINOLOGY. 2024;20(3):185
Consensus Statement on the definition and classification of metabolic hyperferritinaemia (vol 19, pg 299, 2023)
Valenti L; Corradini E; Adams LA; Aigner E; Alqahtani S; Arrese M; Bardou-Jacquet E; Bugianesi E; Fernandez-Real J-M; Girelli D; Hagstroem H; Henninger B; Kowdley K; Ligabue G; Mcclain D; Laine F; Miyanishi K; Muckenthaler MU; Pagani A; Pedrotti P; Pietrangelo A; Prati D; Ryan JD; Silvestri L; Spearman CW; Stal P; Tsochatzis EA; Vinchi F; Zheng M-H; Zoller H
Letter: JOURNAL OF HEPATOLOGY. 2024;56(2):e76-e77
99% of patients with NAFLD meet MASLD criteria and natural history is therefore identical
Hagstroem H; Vessby J; Ekstedt M; Shang Y
Conference publication: ZEITSCHRIFT FUR GASTROENTEROLOGIE. 2024;62(01):e15
Lower incidence of HCC and other major adverse liver outcomes in people living with HIV and chronic liver disease: a population-based cohort study
Michel M; Hagström H; Widman L; Nowak P; Shang Y; Schattenberg JM; Wester A
Letter: UNITED EUROPEAN GASTROENTEROLOGY JOURNAL. 2023;11(9):906
Challenges with neuropsychiatric Wilson's disease
Aberg F; Hagstrom H
Letter: JOURNAL OF INTERNAL MEDICINE. 2023;294(4):537-538
Authors reply: Risk of fractures and postfracture mortality in 3980 people with primary biliary cholangitis
Schoenau J; Wester A; Hagstrom H; Schattenberg JM
Preprint: BIORXIV. 2023
Estrogen receptor activation remodelsTEAD1gene expression to alleviate nonalcoholic fatty liver disease
Sommerauer C; Gallardo-Dodd C; Savva C; Hases L; Birgersson M; Indukuri R; Shen J; Carravilla P; Geng K; Nørskov Søndergaard J; Ferrer-Aumatell C; Mercier G; Sezgin E; Korach-André M; Petersson C; Hagström H; Lauschke V; Archer A; Williams C; Kutter C
Editorial comment: CLINICAL GASTROENTEROLOGY AND HEPATOLOGY. 2023;21(10):2689-2691.e1
Minimal Risk of Hepatocellular Carcinoma in Noncirrhotic Budd-Chiari Syndrome: A Three-Decade Population-Based Study
Wester A; Aberg F; Rajani R; Hagstrom H
Review: JOURNAL OF HEPATOLOGY. 2023;79(3):842-852
Changing epidemiology, global trends and implications for outcomes of NAFLD
Wong VW-S; Ekstedt M; Wong GL-H; Hagstrom H
Conference publication: ZEITSCHRIFT FUR GASTROENTEROLOGIE. 2023;61(08):e472-e473
Lower incidence of HCC and other major adverse liver outcomes in people living with HIV and chronic liver disease: a population-based cohort study
Michel M; Hagström H; Widman L; Nowak P; Shang Y; Schattenberg JM; Wester A
Letter: CLINICAL GASTROENTEROLOGY AND HEPATOLOGY. 2023;21(6):1678
Letter on "Risk of Fractures and Subsequent Mortality in Alcohol-Related Cirrhosis: A Nationwide Population-Based Cohort Study" Reply
Wester A; Hagstrom H
Letter: CLINICAL GASTROENTEROLOGY AND HEPATOLOGY. 2023;21(5):1359-1361.e2
Statins Are Underused in Women With NAFLD After Cardiovascular Events Compared With Matched Control Subjects
Shang Y; Hagstrom H
Review: LIVER INTERNATIONAL. 2023;43(4):763-772
Extra-hepatic morbidity and mortality in alcohol-related liver disease: Systematic review and meta-analysis
Theodoreson MD; Aithal GP; Allison M; Brahmania M; Forrest E; Hagstrom H; Johansen S; Krag A; Likhitsup A; Masson S; McCune A; Rajoriya N; Thiele M; Rowe IA; Parker R
Letter: ALIMENTARY PHARMACOLOGY AND THERAPEUTICS. 2023;57(6):737-738
Letter: comment on Park et al - the association of non-alcoholic fatty liver disease between parents and adolescent children
Hagstroem H; Ludvigsson JF
Editorial comment: ALIMENTARY PHARMACOLOGY AND THERAPEUTICS. 2023;57(6):728
Editorial: moving from the clinic towards population hepatology-authors' reply
Hagstrom H; Hammar N
Letter: JOURNAL OF HEPATOLOGY. 2023;78(2):e66-e67
Considerations in the search for under-reported alcohol consumption in NAFLD.
Hagström H; Ekstedt M
Editorial comment: HEPATOLOGY. 2023;77(2):350-351
Less is more? Screening for steatosis in older populations
Hagstrom H; Shang Y
Conference publication: JOURNAL OF HEPATOLOGY. 2023;78:S654
Prevalence of NAFLD and advanced fibrosis in Stockholm, Sweden
Grip ET; Skroder H; Shang Y; Strom O; Hagstrom H
Conference publication: JOURNAL OF HEPATOLOGY. 2023;78:S710
Implementing a clinical care algorithm for screening of liver fibrosis in specialist diabetes care
Tajudin M; Hoffstedt J; Hagstrom H; Rossner S
Conference publication: HEPATOLOGY. 2023;78:S969-S971
HISTOLOGICAL CLASSIFICATIONS AND PREDICTION OF LIVER- RELATED EVENTS : RESULTS FROM THE MULTICENTRIC, EUROPEAN, HEPATIC OUTCOMES AND SURVIVAL FATTY LIVER REGISTRY ( HOTSURFR) STUDY
Ratziu V; Ampuero J; Boursier J; Kechagias S; Petta S; Hagstrom H; Schattenberg JM; Belin L; Charlotte F; Kara L
Conference publication: HEPATOLOGY. 2023;78:S876-S880
SERIAL VIBRATION CONTROLLED TRANSIENT ELASTOGRAPHY (VCTE)-BASED AGILE SCORES PREDICT LIVER-RELATED EVENTS IN NONALCOHOLIC FATTY LIVER DISEASE (NAFLD) - A MULTICENTER COHORT STUDY OF 16,603 PATIENTS
Lin H; Lee HW; Yip TC-F; Tsochatzis EA; Petta S; Bugianesi E; Yoneda M; Zheng M-H; Hagstrom H; Boursier J; Luis Calleja J; Goh GB-B; Chan WK; Romero-Gomez M; Sanyal A; De Ledinghen V; Newsome PN; Fan J-G; Castera L; Lai M; Harrison SA; Fournier-Poizat CD; Wong GL-H; Pennisi G; Armandi A; Nakajima A; Liu WY; Shang Y; De Saint Loup M; Llop E; Teh KKJ; Lara Romero C; Asgharpour A; Mahgoub S; Chan M; Canivet C; Gallego-Duran R; Kim SU; Wong VW-S
Conference publication: HEPATOLOGY. 2023;78:S853-S854
NOVEL ARTIFICIAL INTELLIGENCE-ASSISTED DIGITAL PATHOLOGY QUANTITATIVE IMAGE ANALYSIS PREDICTS THE OCCURRENCE OF LIVER-RELATED CLINICAL EVENTS IN THE MULTICENTRIC, EUROPEAN, HEPATIC OUTCOMES AND SURVIVAL FATTY LIVER REGISTRY (HOTSURFR) STUDY
Chen L; Petitjean L; Ampuero J; Boursier J; Kechagias S; Petta S; Hagstrom H; Schattenberg JM; Charlotte F; Kara L; Bedossa P; Petitjean MM; Ratziu V
Conference publication: HEPATOLOGY. 2023;78:S928-S931
CLASSIFICATION ACCORDING TO SEQUENTIALLY COMBINED NON-INVASIVE TESTS CARRIES PROGNOSTIC VALUE IN PATIENTS WITH NAFLD
Mozes FE; Kaur S; Vali Y; Alzoubi O; Wong VW-S; Li G; Wong GL-HC; Staufer K; Trauner M; Paternostro R; Stauber RE; Bugianesi E; Gaia S; Armandi A; Lupsor-Platon M; Sebastiani G; Mahadeva S; Rajaram R; Zheng M-H; George J; Eslam MM; Pennisi G; Aithal GP; Palaniyappan N; Lee D; Nasr P; Cassinotto C; De Ledinghen V; Berzigotti A; Mendoza YP; Noureddin M; Truong E; Boursier J; De Saint Loup M; Hirooka M; Shima T; Shalimar; Hagstrom H; Ekstedt M; Akbari C; Chan WK; Tsochatzis EA; Liguori A; Petta S; Vigano M; Ridolfo S; Yoneda M; Nakajima A; Holleboom AG; Van Dijk A-M; Mak AL; Cobbold JFL; Karlas T; Wiegand J; Fournier C; Martic M; Tuthill T; Yunis C; Anstee QM; Harrison S; Bossuyt P; Pavlides M
Book chapter: ALCOHOL AND ALCOHOL-RELATED DISEASES. 2023;p. 953-973
Modulation of Alcohol-Related Liver Disease by Obesity and Diabetes
Hegmar H; Hagström H
Conference publication: JOURNAL OF HEPATOLOGY. 2023;78:S857
Healthcare resource use and costs among patients with primary sclerosing cholangitis in Sweden-a retrospective population-based cohort study
Bergquist A; Kachru N; Aldven M; Strom O; Knutsson D; Grip ET; Hagstrom H
Editorial comment: HEPATOLOGY. 2023;77(1):18-19
A new model for estimation of significant fibrosis in primary care. SAFE to use?
Hagstrom H
Conference publication: HEPATOLOGY. 2023;78:S395-S396
LOWER INCIDENCE OF HCC AND OTHER MAJOR ADVERSE LIVER OUTCOMES IN PEOPLE LIVING WITH HIV AND CHRONIC LIVER DISEASE: A POPULATION-BASED COHORT STUDY
Michel M; Hagstrom H; Widman L; Nowak P; Shang Y; Schattenberg J; Wester A
Conference publication: HEPATOLOGY. 2023;78:S1668-S1669
UPTAKE OF SECONDARY PREVENTIVE DRUGS AFTER MYOCARDIAL INFARCTION IN PATIENTS WITH ALCOHOL-RELATED LIVER DISEASE IS LOW: A NATIONWIDE POPULATION-BASED STUDY
Wester A; Hagstrom H; Jepsen P
Conference publication: JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (AUSTRALIA). 2023;38:96
Sixfold increased risk of acute pancreatitis in patients with alcohol-related liver disease compared with matched controls: A nationwide population-based cohort study
Dugic A; Widman L; Hagstroem H
Conference publication: HEPATOLOGY. 2023;78:S1018-S1020
NASH SEVERITY ASSESSED BY THE NAFLD ACTIVITY SCORE (NAS) DOES NOT ADD PROGNOSTIC INFORMATION TO FIBROSIS STAGE IN PATIENTS WITH NAFLD
Mozes FE; Kaur S; Vali Y; Alzoubi O; Wong VW-S; Li G; Wong GL-HC; Staufer K; Trauner M; Paternostro R; Stauber RE; Bugianesi E; Gaia S; Armandi A; Lupsor-Platon M; Sebastiani G; Mahadeva S; Rajaram R; Zheng M-H; George J; Eslam MM; Pennisi G; Aithal GP; Palaniyappan N; Lee D; Nasr P; Cassinotto C; De Ledinghen V; Berzigotti A; Mendoza YP; Noureddin M; Truong E; Boursier J; De Saint Loup M; Hirooka M; Shima T; Dr S; Hagstrom H; Ekstedt M; Akbari C; Chan WK; Tsochatzis EA; Liguori A; Petta S; Vigano M; Ridolfo S; Yoneda M; Nakajima A; Holleboom AG; Van Dijk A-M; Mak AL; Cobbold JFL; Karlas T; Wiegand J; Fournier C; Martic M; Tuthill T; Yunis C; Anstee QM; Harrison S; Bossuyt P; Pavlides M
Conference publication: HEPATOLOGY. 2023;78:S995-S998
LIVER STIFFNESS MEASUREMENT BASED COMPOSITE SCORES HAVE COMPARABLE PROGNOSTIC PERFORMANCE TO HISTOLOGICALLY ASSESSED FIBROSIS STAGE
Mozes FE; Kaur S; Vali Y; Alzoubi O; Wong VW-S; Li G; Wong GL-HC; Staufer K; Trauner M; Paternostro R; Stauber RE; Bugianesi E; Gaia S; Armandi A; Lupsor-Platon M; Sebastiani G; Mahadeva S; Rajaram R; Zheng M-H; George J; Eslam MM; Pennisi G; Aithal GP; Palaniyappan N; Lee D; Nasr P; Cassinotto C; De Ledinghen V; Berzigotti A; Mendoza YP; Noureddin M; Truong E; Boursier J; De Saint Loup M; Hirooka M; Shima T; Dr S; Hagstrom H; Ekstedt M; Akbari C; Chan WK; Tsochatzis EA; Liguori A; Petta S; Vigano M; Ridolfo S; Yoneda M; Nakajima A; Holleboom AG; Van Dijk A-M; Mak AL; Cobbold JFL; Karlas T; Wiegand J; Fournier C; Martic M; Tuthill T; Yunis C; Anstee QM; Harrison S; Bossuyt P; Pavlides M
Conference publication: HEPATOLOGY. 2023;78:S971-S974
HISTOLOGICALLY ASSESSED FIBROSIS IS THE MAIN DETERMINANT OF PROGNOSIS IN PATIENTS IN NAFLD
Mozes FE; Kaur S; Vali Y; Alzoubi O; Wong VW-S; Li G; Wong GL-HC; Staufer K; Trauner M; Paternostro R; Stauber RE; Bugianesi E; Gaia S; Armandi A; Lupsor-Platon M; Sebastiani G; Mahadeva S; Rajaram R; Zheng M-H; George J; Eslam MM; Pennisi G; Aithal GP; Palaniyappan N; Lee D; Nasr P; Cassinotto C; De Ledinghen V; Berzigotti A; Mendoza YP; Noureddin M; Truong E; Boursier J; De Saint Loup M; Hirooka M; Shima T; Shalimar; Hagstrom H; Ekstedt M; Akbari C; Chan WK; Tsochatzis EA; Liguori A; Petta S; Vigano M; Ridolfo S; Yoneda M; Nakajima A; Holleboom AG; Van Dijk A-M; Mak AL; Cobbold JFL; Karlas T; Wiegand J; Fournier C; Martic M; Tuthill T; Yunis C; Anstee QM; Harrison S; Bossuyt P; Pavlides M
Conference publication: HEPATOLOGY. 2023;78:S932-S935
COMPOSITE SCORES THAT INCLUDE LIVER STIFFNESS MEASUREMENT CAN PREDICT OUTCOMES IN PATIENTS WITH NAFLD
Mozes FE; Kaur S; Vali Y; Alzoubi O; Wong VW-S; Li G; Wong GL-HC; Staufer K; Trauner M; Paternostro R; Stauber RE; Bugianesi E; Gaia S; Armandi A; Lupsor-Platon M; Sebastiani G; Mahadeva S; Rajaram R; Zheng M-H; George J; Eslam MM; Pennisi G; Aithal GP; Palaniyappan N; Lee D; Nasr P; Cassinotto C; De Ledinghen V; Berzigotti A; Mendoza YP; Noureddin M; Truong E; Boursier J; De Saint Loup M; Hirooka M; Shima T; Shalimar D; Hagstrom H; Ekstedt M; Akbari C; Chan WK; Tsochatzis EA; Liguori A; Petta S; Vigano M; Ridolfo S; Yoneda M; Nakajima A; Holleboom AG; Van Dijk A-M; Mak AL; Cobbold JFL; Karlas T; Wiegand J; Fournier C; Martic M; Tuthill T; Yunis C; Anstee QM; Harrison S; Bossuyt P; Pavlides M
Conference publication: PANCREATOLOGY. 2022;22:e2-e3
Post-pancreatitis diabetes mellitus Ц a high-volume tertiary center experience
Dugic A; Hagström H; Dahlman I; Rutkowski W; Daou D; Kulinski P; Löhr M; Vujasinovic M
Other: UNITED EUROPEAN GASTROENTEROLOGY JOURNAL. 2022;10(8):898
In memoriam: Rolf Hultcrantz (1949-2022)
Hagstrom H; Simren M; Ekbom A
Review: JOURNAL OF INTERNAL MEDICINE. 2022;292(2):177-189
Risk for hepatic and extra-hepatic outcomes in nonalcoholic fatty liver disease
Hagstrom H; Kechagias S; Ekstedt M
Conference publication: HEPATOLOGY. 2022;76:S800-S801
THE RELATIONSHIP BETWEEN LIVER HISTOLOGY AND LONG-TERM CLINICAL OUTCOMES IN PATIENTS WITH NON-ALCOHOLIC STEATOHEPATITIS: A REAL-WORLD COHORT STUDY
Younossi ZM; Mangla KK; Berentzen TL; Grau K; Kjaer MS; Ladelund S; Nitze LM; Coolbaugh C; Hsu C-Y; Hagstrom H
Conference publication: HEPATOLOGY. 2022;76:S818-S820
REAL-WORLD EVIDENCE ON NON-INVASIVE TESTS AND ASSOCIATED CUT-OFFS USED TO ASSESS FIBROSIS IN ROUTINE CLINICAL PRACTICE
Lazarus JV; Castera L; Mark H; Adams LA; Allen AM; Anstee QM; Arrese M; Alqahtani S; Bugianesi E; Colombo M; Cusi K; Hagstrom H; Loomba R; Romero-Gomez M; Schattenberg JM; Thiele M; Valenti L; Wong V; Yilmaz Y; Younossi ZM; Francque SM; Tsochatzis EA
Conference publication: JOURNAL OF HEPATOLOGY. 2022;77:S141
Refining the natural history of alcohol related liver disease: a competing risk analysis
Parker R; Aithal G; Allison M; Arab JP; Brahmania M; Forrest E; Hagstrom H; Likhitsup A; Masson S; McCune A; Rajoriya N; Rowe I
Conference publication: JOURNAL OF HEPATOLOGY. 2022;77:S413
Health outcomes and risk assessment in chronic liver disease (HERALD): a large Swedish research platform
Grip ET; Strom O; Hagstrom H
Conference publication: HEPATOLOGY. 2022;76:S8-S10
PROGNOSTIC VALUE OF NON-INVASIVE TESTS IN PATIENTS WITH NAFLD
Mozes FE; Lee J; Alzoubi O; Wong V; Li G; Wong GL; Boursier J; Saint Loup MD; Hirooka M; Shima T; Shalimar; Hagstrom H; Ekstedt M; Akbari C; Chan WK; Tsochatzis EA; Liguori A; Petta S; Vigano M; Ridolfo S; Yoneda M; Nakajima A; Holleboom AG; Van Dijk A-M; Mak AL; Cobbold JF; Karlas T; Wiegand J; Fournier CD; Martic M; Tuthill T; Yunis C; Anstee QM; Harrison SA; Bossuyt P; Pavlides M
Conference publication: GASTROENTEROLOGY. 2022;162(7):S1270-S1271
NON-INVASIVE TESTS (NITS) FOR PREDICTING HEPATOCELLULAR CARCINOMA IN NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) PATIENTS WITHOUT CIRRHOSIS: A SYSTEMATIC REVIEW AND META-ANALYSIS OF INDIVIDUAL PATIENT DATA AND AGGREGATE DATA
Siriwong N; Sriphoosanaphan S; Yongpisarn T; Apiparakoon T; Tiyarattanachai T; Kerr SJ; Treeprasertsuk S; Hagstrom H; Akbari C; Ekstedt M; Ito T; Ishigami M; Toyoda H; Hino K; Kawanaka M; Sumida Y; Seko Y; Peleg N; Shlomai A; Yip TCF; Wong GL; Chaiteerakij R
Conference publication: HEPATOLOGY. 2022;76:S1133-S1134
RISK OF INJURY BEFORE AND AFTER DIAGNOSIS OF CIRRHOSIS: A SELF-CONTROLLED CASE SERIES STUDY
Shang Y; Shen Q; Tapper EB; Wester A; Hagstrom H
Conference publication: JOURNAL OF HEPATOLOGY. 2022;77:S423
The PNPLA3 (rs738409) G/G-genotype is associated with presence of NASH and increased long-term risk of cirrhosis in NAFLD
Holmer M; Zenlander R; Wester A; Ekstedt M; Nasr P; Kechagias S; Romeo S; Stal P; Hagstrom H
Conference publication: JOURNAL OF HEPATOLOGY. 2022;77:S30
Liver stiffness predicts incident severe liver disease in patients with chronic liver disease
Hegmar H; Wester A; Aleman S; Backman J; Degerman E; Ekvall H; Lund K; Lundgren A; Nasr P; Shahnavaz A; Vessby J; Westin J; Onnerhag K; Hagstrom H
Conference publication: HEPATOLOGY. 2022;76:S1491
RISK OF FRACTURES AND POST-FRACTURE MORTALITY IN PRIMARY BILIARY CHOLANGITIS: A POPULATION-BASED COHORT STUDY OF 3,980 PATIENTS
Wester A; Schoenau J; Schattenberg JM; Hagstroem H
Conference publication: JOURNAL OF HEPATOLOGY. 2022;77:S189
MAIT-cells in blood are associated with a higher risk of infection in patients with cirrhosis
Bengtsson B; Maucourant C; Shang Y; Sandberg JK; Bjorkstrom N; Hagstrom H
Conference publication: HEPATOLOGY. 2022;76:S949
TIME TRENDS FOR MORTALITY AND LIFE EXPECTANCY IN 22,658 PATIENTS HOSPITALIZED WITH ALCOHOL-RELATED CIRRHOSIS IN SWEDEN: A NATIONWIDE COHORT STUDY
Wester A; Shang Y; Hagstrom H
Conference publication: DIABETOLOGIA. 2022;65(SUPPL 1):S9
Increased risk for microvascular outcome in NAFLD: a nationwide, population-based cohort study
Ebert T; Widman L; Stenvinkel P; Hagstrom H
Conference publication: JOURNAL OF HEPATOLOGY. 2022;77:S119-S120
Biomarkers for prediction of alcohol-related liver cirrhosis in the Swedish general population
Jakobsson G; Talback M; Walldius G; Hammar N; Hagstrom H
Conference publication: JOURNAL OF HEPATOLOGY. 2022;77:S82
Incidence, prevalence and mortality of chronic liver diseases in Sweden between 2005 and 2019
Nasr P; Ndegwa N; von Seth E; Ludvigsson J; Hagstrom H
Conference publication: HEPATOLOGY. 2022;76:S620-S621
ADDITIONAL COMPONENTS OF THE METABOLIC SYNDROMES INCREASE THE RISK FOR SEVERE LIVER DISEASE IN PATIENTS WITH TYPE 2 DIABETES IN A DOSE-DEPENDENT MANNER
Shang Y; Toresson-Grip E; Ntanios F; Modica A; Strom O; Hagstrom H
Conference publication: JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (AUSTRALIA). 2022;37:48
Post-pancreatitis diabetes mellitus: A high-volume tertiary center experience
Dugic A; Hagstrom H; Dahlman I; Rutkowski W; Daou D; Kulinski P; Lohr JM; Vujasinovic M
Conference publication: JOURNAL OF HEPATOLOGY. 2022;77:S123
Risk of fractures and subsequent mortality in alcohol-related cirrhosis: a nationwide population-based cohort study
Wester A; Ndegwa N; Hagstrom H
Conference publication: JOURNAL OF HEPATOLOGY. 2022;77:S530
Cancer risk in acute hepatic porphyria: a nationwide matched cohort study in 1, 245 individuals
Lissing M; Vassiliou D; Floderus Y; Yan J; Hagstrom H; Sardh E; Wahlin S
Conference publication: JOURNAL OF HEPATOLOGY. 2022;77:S24
Prediction of ten-year risk of severe liver disease in the general population using commonly available biomarkers
Hagstrom H; Yan J; Talback M; Andreasson A; Walldius G; Bottai M; Hammar N
Letter: JHEP REPORTS. 2021;3(6):100366
Reply to: "Reduced steatosis and weight as a result of specific diets or the dietitian themselves"
Holmer M; Lindqvist C; Hagstrom H; Stal P
Letter: CLINICAL GASTROENTEROLOGY AND HEPATOLOGY. 2021;19(12):2675-2676.e2
Bariatric Surgery Versus Standard Obesity Treatment and the Risk of Severe Liver Disease: Data From the Swedish Obese Subjects Study
Hagstrom H; Ekstedt M; Olbers T; Peltonen M; Carlsson L
Review: JOURNAL OF INTERNAL MEDICINE. 2021;290(3):602-620
Technological readiness and implementation of genomic-driven precision medicine for complex diseases
Franks PW; Melen E; Friedman M; Sundstrom J; Kockum I; Klareskog L; Almqvist C; Bergen SE; Czene K; Hagg S; Hall P; Johnell K; Malarstig A; Catrina A; Hagstrom H; Benson M; Smith JG; Gomez MF; Orho-Melander M; Jacobsson B; Halfvarson J; Repsilber D; Oresic M; Jern C; Melin B; Ohlsson C; Fall T; Ronnblom L; Wadelius M; Nordmark G; Johansson A; Rosenquist R; Sullivan PF
Preprint: MEDRXIV. 2021
A Sustainable Development Goal framework to guide multisectoral action on NAFLD through a societal approach
Lazarus JV; Mark HE; Colombo M; Demaio S; Dillon JF; George J; Hagström H; Hocking S; Lee N; Nieuwenhuijsen MJ; Rinella ME; Romero-Gomez M; Soriano JB; Schattenberg JM; Tacke F; Tsochatzis EA; Valenti L; Zelber-Sagi S; Dirac MA; Huang TT-K
Conference publication: PANCREATOLOGY. 2021;21:s38
Risk of developing pancreatic cancer in patients with chronic pancreatitis
Vujasinovic M; Dugic A; Maisonneuve P; Aljic A; Berggren R; Panic N; Valente R; Mucelli RP; Waldthaler A; Ghorbani P; Kordes M; Hagström H; Löhr M
Conference publication: HEPATOLOGY. 2021;74:219A-220A
INCIDENCE AND PREDICTORS OF NON-HEPATIC CANCERS IN ALCOHOL RELATED LIVER DISEASE
Hindi Z; Shi N; Brahmania M; Pablo Arab J; Rajoriya N; Aithal GP; Allison ME; Hagstrom H; Likhitsup A; McCune A; Masson S; Parker R
Conference publication: JOURNAL OF HEPATOLOGY. 2021;75:S488
External validation of the Toronto hepatocellular carcinoma risk index in a Swedish population
Astrom H; Ndegwa N; Hagstrom H
Conference publication: JOURNAL OF HEPATOLOGY. 2021;75:S692-S693
Three-fold increased risk for death in Budd-Chiari syndrome compared to matched controls-population-based cohort study
Aberg F; Widman L; Rajani R; Hagstrom H
Conference publication: JOURNAL OF HEPATOLOGY. 2021;75:S251-S252
Life expectancy and risk of cardiovascular disease in non-alcoholic fatty liver disease: a population-based cohort study
Shang Y; Nasr P; Widman L; Hagstrom H
Conference publication: JOURNAL OF HEPATOLOGY. 2021;75:S554
Indirect healthcare costs in biopsy-proven NAFLD is higher than in matched controls and independent of comorbidities
Gruneau L; Widman L; Henriksson M; Hagstrom H
Conference publication: JOURNAL OF HEPATOLOGY. 2021;75:S557-S558
The prognosis is impaired in NAFLD patients with diabetes despite negative FIB4 <1.30
Boursier J; Ekstedt M; Gomez MR; Moreau C; Bonacci M; Cure S; Trylesinski A; Hagstrom H
Preprint: SSRN ELECTRONIC JOURNAL. 2021
Pregnancy Outcomes in Women with Autoimmune Hepatitis – a Nationwide Population-Based Cohort Study with Histopathology
Sharma R; Simon TG; Stephansson O; Verna EC; Emond J; Söderling J; Roelstraete B; Hagström H; Ludvigsson JF
Conference publication: JOURNAL OF HEPATOLOGY. 2021;75:S269
Treatment of NAFLD with intermittent calorie restriction, low-carb high-fat diet or standard dietary advice-a randomized controlled trial
Holmer M; Lindqvist C; Petersson S; Moshtaghi-Svensson J; Tillander V; Brismar T; Hagstrom H; Stal P
Editorial comment: ALIMENTARY PHARMACOLOGY AND THERAPEUTICS. 2020;51(11):1204-1205
Editorial: can urine-based metabolomics improve diagnosis of advanced fibrosis in NAFLD?
Hagstrom H
Review: GASTROENTEROLOGY. 2020;158(6):1611-1625.e12
Association Between Fibrosis Stage and Outcomes of Patients With Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta -Analysis
Taylor RS; Taylor RJ; Bayliss S; Hagstrom H; Nasr P; Schattenberg JM; Ishigami M; Toyoda H; Wong VW-S; Peleg N; Shlomai A; Sebastiani G; Seko Y; Bhala N; Younossi ZM; Anstee QM; McPherson S; Newsome PN
Conference publication: HEPATOLOGY. 2020;72:378A-379A
A SYSTEMATIC REVIEW OF COMPREHENSIVE MODELS OF CARE FOR NAFLD AND NASH
Lazarus JV; Mark HE; Cortez-Pinto H; Hagstrom H; Villota M; Wong V; Zelber-Sagi S; Romero-Gomez M; Schattenberg JM
Conference publication: JOURNAL OF HEPATOLOGY. 2020;73:S166-S167
Europe's largest meta-analysis on the prevalence of non-alcoholic fatty liver disease, non-alcoholic steatohepatitis and advanced fibrosis (F3-F4)
Petta S; Hagstrom H; Geier A; Ratziu V; Caballeria L; Exposito C; Hernandez R; Blokzijl H; De Knegt R; Ferrinho D; Ntalla I; Smith A; Ramroth H; Newsome PN
Conference publication: JOURNAL OF HEPATOLOGY. 2020;73:S562
Treatment with sorafenib on hepatocellular carcinoma-10 years' experience in a nursing-led outpatient clinic
Grujcic G; Loqvist P; Hagstrom H
Conference publication: JOURNAL OF HEPATOLOGY. 2020;73:S420
Macrophage markers do not add to the prediction of liver fibrosis by transient elastography in patients with non-alcoholic fatty liver disease
Kazankov K; Rosso C; Younes R; Hagstrom H; Moller HJ; Stal P; Bugianesi E; Gronbaek H
Conference publication: GASTROENTEROLOGY. 2020;158(6):S1285-S1286
MORTALITY RISK IN BIOPSY-VERIFIED AUTOIMMUNE HEPATITIS: A NATIONWIDE POPULATION-BASED COHORT STUDY
Sharma R; Verna EC; Soderling J; Roelstraete B; Hagstrom H; Ludvigsson JF
Conference publication: JOURNAL OF HEPATOLOGY. 2020;73:S63
Primary liver cancer in acute hepatic porphyria: a national cohort study
Lissing M; Vassiliou D; Floderus Y; Harper P; Bottai M; Kotopouli M; Hagstrom H; Sardh E; Wahlin S
Conference publication: HEPATOLOGY. 2020;72:967
FIB-4 AND FIBROSCAN CAN IDENTIFY PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE WHO ARE AT RISK OF LIVER-RELATED EVENTS: RESULTS OF A LONGITUDINAL ANALYSIS WITH COMPARISON WITH LIVER BIOPSY
Boursier J; Hagstrom H; Ekstedt M; Moreau C; Bonacci M; Cures S; Trylesinski A; Romero-Gomez M
Conference publication: JOURNAL OF HEPATOLOGY. 2020;73:S128-S129
Bariatric surgery is not associated with a reduction in risk of severe liver disease in comparison to standard obesity treatment in 3,922 subjects
Hagstrom H; Ekstedt M; Olbers T; Peltonen M; Carlsson L
Conference publication: JOURNAL OF HEPATOLOGY. 2020;73:S541
Prognosis in persons with an HFE-mutation: population-based cohort study of 3,645 individuals
Hagstrom H; Ndegwa N; Ekstedt M; Posserud I; Rorsman F; Nyhlin N; Klintman D; Werner M; Marschall H-U; Askling J; Stal P
Conference publication: JOURNAL OF HEPATOLOGY. 2020;73:S108
Liver disease progression and clinical outcomes in hepatic outcomes and survival fatty liver registry (HOTSURFR) study
Kutala B; Boursier J; Ekstedt M; Hagstrom H; Pais R; Bugianesi E; George J; Schattenberg JM; Anstee Q; Bedossa P; Ratziu V
Conference publication: JOURNAL OF HEPATOLOGY. 2020;73:S178
Mortality in biopsy-proven alcohol-related liver disease: population-based cohort study of 3,453 individuals
Hagstrom H; Thiele M; Roelstraete B; Soderling J; Ludvigsson JF
Conference publication: JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (AUSTRALIA). 2020;35:35
Etiology and natural course of chronic pancreatitis
Dugic A; Berggren R; Aljic A; Waldthaler A; Panic N; Valente R; Pozzi-Mucelli R; Ghorbani P; Maisonneuve P; Hagstrom H; Lohr M; Vujasinovic M
Conference publication: JOURNAL OF HEPATOLOGY. 2020;73:S70-S71
Repeated measures of FIB-4 improve prediction of severe liver disease: population-based cohort study of 40,729 individuals
Hagstrom H; Talback M; Andreasson A; Walldius G; Hammar N
Conference publication: JOURNAL OF HEPATOLOGY. 2020;73:S371-S372
Long-term risk of HCC in persons with cirrhosis: national, population-based cohort study of 7,322 individuals
Bengtsson B; Widman L; Wahlin S; Stal P; Bjorkstrom N; Hagstrom H
Letter: CLINICAL GASTROENTEROLOGY AND HEPATOLOGY. 2019;17(12):2619-2620
Predictive Capacity for Mortality and Severe Liver Disease of the Relative Fat Mass Algorithm
Andreasson A; Carlsson AC; Onnerhag K; Hagstrom H
Editorial comment: EXPERT REVIEW OF GASTROENTEROLOGY AND HEPATOLOGY. 2019;13(7):603-605
Is teenage heavy drinking more hazardous than we thought?
Hagstrom H; Andreasson A
Letter: HEPATOLOGY COMMUNICATIONS. 2019;3(6):848
The Time Is Now for Mandatory Liver-Focused Clinical Experiences in Medical School REPLY
Hagstrom H; Williamson C; Marschall H-U
Meeting abstract: JOURNAL OF HEPATOLOGY. 2019;70(1):E817-E818
Transient elastography in normal pregnancies: A prospective cohort study
Ribeiro MS; Stal P; Hagstrom H; Ajne G
Conference publication: HEPATOLOGY. 2019;70:755A-756A
THE PREDICTED BENEFITS OF TREATMENTS FOR NONALCOHOLIC STEATOHEPATITIS ARE LIMITED IN PATIENTS WITHOUT CIRRHOSIS
Rowe I; Hagstrom H; Ekstedt M; Parker R
Conference publication: HEPATOLOGY. 2019;70:1093A
GOLEXANOLONE EXHIBITS LITTLE GENDER DIFFERENCE IN PHARMACOKINETICS AND IS WELL TOLERATED BY PATIENTS WITH CIRRHOSIS AT PLASMA LEVELS SHOWN TO MITIGATE THE CNS EFFECTS OF ALLOPREGNANOLONE.
Berglund JE; Rorsman F; Zupanets I; Partinen M; Jennum P; Lakner G; Wasling P; Hagstrom H; Kechagias S; Lamusuo S; Ocklind C; Arlander E; Backstrom T; Doverskog M; Johansson M; Mansson M; Samuelson P; Schalling M; Wennerholm A; Scharschmidt BF
Conference publication: JOURNAL OF HEPATOLOGY. 2019;70(1):E769
Prediction of incident severe liver disease in the general population using non-invasive scoring systems
Hagstrom H; Talback M; Andreasson A; Carlsson A; Walldius G; Hammar N
Editorial comment: ALIMENTARY PHARMACOLOGY AND THERAPEUTICS. 2018;48(9):1017-1018
Editorial: severe outcomes are rare in pregnancy with autoimmune hepatitis
Hagstrom H; Ludvigsson JF
Letter: JOURNAL OF HEPATOLOGY. 2018;69(1):252-253
Reply to: "A measure of alcohol consumption in late adolescence associated with liver disease after 39 years of follow-up is insufficient to guide alcohol safe limits"
Hagstrom H; Hemmingsson T; Discacciati A; Andreasson A
Conference publication: JOURNAL OF HEPATOLOGY. 2018;68:S693-S694
Outcomes of pregnancy in women with cirrhosis - a national, population-based cohort study
Hagstrom H; Hoijer J; Marschall H-U; Williamson C; Heneghan M; Westbrook R; Ludvigsson JF; Stephansson O
Conference publication: JOURNAL OF HEPATOLOGY. 2018;68:S573-S574
A new score to predict presence of advanced fibrosis in NAFLD and comparison with established scoring systems
Hagstrom H; Nasr P; Ekstedt M; Hammar U; Hultcrantz R; Stal P; Kechagias S
Conference publication: HEPATOLOGY. 2018;68:781A-782A
Type and Pattern of Alcohol Consumption in Adolescent Men and Risk of Severe Liver Disease Later in Life: A National, Population-Based Cohort Study
Hagstrom H; Discacciat AI; Hemmingsson T; Andreasson A
Conference publication: HEPATOLOGY. 2018;68:999A-1000A
A Lifestyle Intervention in Patients with Type 2 Diabetes Aimed to Improve Glycemic Control Also Reduces Hepatic Stiffness
Bjorkstrom K; Stal P; Holmer M; Bengtsson B; Staaf A; Hoffstedt J; Hagstrom H
Conference publication: HEPATOLOGY. 2018;68:993A-994A
Health Care Costs Associated with NAFLD - a Long-Term Follow up Study
Hagstrom H; Nasr P; Ekstedt M; Hammar U; Stal P; Hultcrantz RW; Kechagias S; Henriksson M
Conference publication: HEPATOLOGY. 2018;68:950A
Cardiovascular Risk Factors in Non-Alcoholic Fatty Liver Disease
Hagstrom H; Nasr P; Ekstedt M; Hammar U; Stal P; Hultcrantz RW; Kechagias S
Conference publication: HEPATOLOGY. 2018;68:970A-971A
High Body Mass Index in Young Adulthood and Future Risk of Severe Liver Disease: A National, Population-Based Cohort Study in 1.1 Million Women
Hagstrom H; Hoijer J; Andreasson A; Bottai M; Johansson K; Ludvigsson JF; Stephansson O
Conference publication: JOURNAL OF HEPATOLOGY. 2018;68:S823
Risk factors for development of severe liver disease in more than 400 000 patients with type 2 diabetes: A population-based cohort study
Bjorkstrom K; Franzen S; Eliasson B; Miftaraj M; Gudbjornsdottir S; Trolle-Lagerros Y; Svensson A-M; Hagstrom H
Conference publication: HEPATOLOGY. 2018;68:59A-60A
Lipophilic Statins and Risk of Hepatocellular Carcinoma and Mortality: A Prospective, Nationwide Population with Chronic Viral Hepatitis
Simon TG; Duberg A-S; Aleman S; Hagstrom H; Chung RT; Ludvigsson JF
Review: HEPATOLOGY. 2017;65(5):1557-1565
Increased Risk of Mortality by Fibrosis Stage in Nonalcoholic Fatty Liver Disease: Systematic Review and Meta-Analysis
Dulai PS; Singh S; Patel J; Soni M; Prokop LJ; Younossi Z; Sebastiani G; Ekstedt M; Hagstrom H; Nasr P; Stal P; Wong VW-S; Kechagias S; Hultcrantz R; Loomba R
Review: CURRENT HEPATITIS REPORTS. 2017;16(2):152-157
Alcohol Consumption in Concomitant Liver Disease: How Much is Too Much?
Hagström H
Conference publication: JOURNAL OF HEPATOLOGY. 2017;66(1):S71
High BMI in late adolescence predicts future severe liver disease: a national, population-based cohort study in 1.2 million men
Hagstroem H; Tynelius P; Rasmussen F
Conference publication: JOURNAL OF HEPATOLOGY. 2017;66(1):S421-S422
NAFLD as an indication for liver transplantation in the Nordic countries - a cohort study during 1982-2015
Holmer M; Melum E; Isoniemi H; Ericzon B-G; Castedal M; Nordin A; Schultz NA; Rasmussen A; Line P-D; Stal P; Bennet W; Hagstrom H
Letter: HEPATOLOGY. 2016;64(1):310-311
Nonalcoholic Fatty Liver Disease Activity Score and Mortality: Imperfect But Not Insignificant REPLY
Ekstedt M; Hagstrom H; Nasr P; Fredrikson M; Stal P; Kechagias S; Hultcrantz R
Thesis / dissertation: 2016
The importance of fat and alcohol for progression and prognosis in chronic liver disease
Hagström, Hannes
Review: LAKARTIDNINGEN. 2016;113:DL6L
[Infections common in acute and chronic liver disease].
Hagström H; Rorsman F
Conference publication: HEPATOLOGY. 2016;64:531A
Fibrosis progression and mortality in non-alcoholic fatty liver disease
Elfwen O; Stal P; Hultcrantz RW; Hagstrom H
Conference publication: HEPATOLOGY. 2016;64:18A-19A
Low to moderate lifetime alcohol consumption is associated with less advanced stages of fibrosis in non-alcoholic fatty liver disease
Hagstrom H; Nasr P; Ekstedt M; Kechagias S; Onnerhag K; Nilsson E; Rorsman F; Sheikhi R; Marschall H-U; Stal P; Hultcrantz RW
Conference publication: HEPATOLOGY. 2016;64:552A-553A
Risk of Mortality by Fibrosis Stage in NAFLD: A Systematic Review and Meta-Analysis
Patel JR; Dulai PS; Younossi ZM; Sebastiani G; Ekstedt M; Hagstrom H; Nasr P; Stal P; Kechagias S; Hultcrantz RW; Singh S; Loomba R
Conference publication: JOURNAL OF HEPATOLOGY. 2016;64:S135
SAF SCORE AS A MARKER FOR MORTALITY IN NAFLD AFTER UP TO 41 YEARS OF FOLLOW-UP
Hagstrom H; Ekstedt PNM; Bedossa P; Stal P; Kechagias S; Hultcrantz R
Conference publication: HEPATOLOGY. 2016;64:531A
Risk factors for type 2 diabetes mellitus development in non-alcoholic fatty liver disease after up to 41 years follow-up
Bjorkstrom NK; Stal P; Hultcrantz RW; Hagstrom H
Conference publication: HEPATOLOGY. 2015;62:368A
Tacrolimus or Mycophenylate mofetil as a second-line therapeutic options in patients with Autoimmune Hepatitis: An international multicentre observational study
Efe C; Hagstrom H; Bhanji RA; Mueller NF; Wang Q; Purnak T; Muratori L; Werner M; Marschall H-U; Muratori P; Gunsar F; Klintman D; Pares A; Heurgue-Berlot A; Schiano TD; Ma X; Montano-Loza AJ; Berg T; Ozaslan E; Yoshida EM; Wahlin S
Conference publication: HEPATOLOGY. 2015;62:289A
Overweight in late adolescence is associated with decompensated liver disease later in life after 39 years of follow-up
Hagstrom H; Stal P; Hultcrantz RW; Hemmingsson T; Andreasson A
Review: PLOS MEDICINE. 2014;11(7):e1001680
Association of Non-alcoholic Fatty Liver Disease with Chronic Kidney Disease: A Systematic Review and Meta-analysis
Musso G; Gambino R; Tabibian JH; Ekstedt M; Kechagias S; Hamaguchi M; Hultcrantz R; Hagstrom H; Yoon SK; Charatcharoenwitthaya P; George J; Barrera F; Haflioadottir S; Bjornsson ES; Armstrong MJ; Hopkins LJ; Gao X; Francque S; Verrijken A; Yilmaz Y; Lindor KD; Charlton M; Haring R; Lerch MM; Rettig R; Voelzke H; Ryu S; Li G; Wong LL; Machado M; Cortez-Pinto H; Yasui K; Cassader M
Conference publication: HEPATOLOGY. 2014;60:604A
Adverse outcomes of pregnancy in mothers with NAFLD and their offspring
Hagstrom H; Ludvigsson JF; Ekbom A; Hultcrantz RW; Stephansson O; Stokkeland K
Conference publication: HEPATOLOGY. 2013;58(6):1380A-1381A
Fibrosis stage, but not NAS, is predictive for disease-specific mortality in NAFLD after 33 years of follow-up
Ekstedt M; Hagstrom H; Nasr PS; Fredrikson M; Stal P; Kechagias S; Hultcrantz RW
Visa fler

Forskningsbidrag

Hagström, Hannes Olle Erik - Improved prediction and treatment of liver cancer - population-based studies
Swedish Cancer Society
1 January 2023
Omega-3 fatty acids as immunosupressive supplement after organ transplantation - national, randomized, double-blind study.
Swedish Research Council
1 January 2022 - 31 December 2023
Improved diagnostics and prognostication of chronic liver disease
Swedish Research Council
1 January 2022 - 31 December 2025
Liver cancer caused by diabetes and fatty liver - identification of risk groups and protective factors
Swedish Cancer Society
1 January 2020
Liver cancer caused by diabetes and fatty liver - identification of risk groups and protective factors
Swedish Cancer Society
1 January 2019

Anställningar

Adjungerad Professor, Medicin, Huddinge, Karolinska Institutet, 2024-2028
Anknuten till Forskning, Medicin, Huddinge, Karolinska Institutet, 2023-2026

Examina och utbildning

Docent, gastroenterologi och hepatologi, Karolinska Institutet, 2019
Medicine Doktorsexamen, Institutionen för medicin, Huddinge, Karolinska Institutet, 2016
Läkarexamen, Karolinska Institutet, 2007

Handledare

Andrea Lindfors, 2021
Hannes Hegmar, 2020
Karl Björkström, From fatty liver to end-stage liver disease through type 2 diabetes, https://www.avhandlingar.se/avhandling/cf512e5847/
Bonnie Bengtsson, Liver cirrhosis - epidemiology, prognosis, and cancer

Nyheter från KI

Kalenderhändelser från KI